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Abstract 
 
  
Fenugreek (Trigonella foenum-graecum L.) is a medicinal plant with potential 
applications in the natural health product industry. In a multi-environmental setting, 10 
genotypes were tested across 14 growing environments (using a Randomized Complete 
Block Design), representing irrigated and rainfed growing conditions in southern Alberta, 
Canada over two cropping years (2006 and 2007). The objectives of this study were (1) to 
determine seed yield, plus content and productivity of selected bioactive compounds 
(galactomannan, diosgenin and 4-hydroxyisoleucine), (2) to assess the impact of growing 
environment on these variables and (3) to identify promising genotypes for breeding and 
industrial use. Using principal component and cluster analyses, the study provides insight 
on the relative influence of growing environments and genes on the biochemical and 
agronomical traits as well as identifies genotypes based on performance and stability. 
These are useful as parental materials in cultivar development for the Canadian natural 
health product industry.  
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1.0 Introduction 
 
Fenugreek (Trigonella foenum-graecum L.) is a self-pollinating, annual 
leguminous crop (Fig. 1.1), which is native to the Indian subcontinent and the Eastern 
Mediterranean region (Petropoulos, 2002). It is currently widely cultivated in central 
Asia, central Europe, northern Africa, North America and parts of Australia, with India 
being the leading fenugreek producer in the world (Fotopoulos, 2002). The plant is well 
suited to cool and temperate growing regions with low to moderate rainfall. Fenugreek is 
adapted to rainfed growing conditions and is suitable for growth within the semi-arid 
regions of western Canada especially those genotypes of Mediterranean origin due to 
similarity in day length (Acharya et al., 2008).  
Fenugreek, perhaps, is best known for presence of the distinctive, pungent 
aromatic compounds in the seed (Max, 1992) that impart flavour, color and aroma to 
foods, making it a highly desirable supplement for use in culinary applications. As a 
spice, it constitutes one of the many ingredients that make up curry powders (Srinivasan, 
2006). In countries such as India, fenugreek leaves are consumed as leafy vegetables in 
the diet (Sharma, 1986b), while in Ethiopia and Egypt, the plant is used as a supplement 
in maize and wheat flour for bread-making (Al-Habori and Raman, 2002). In Yemen and 
Persia, fenugreek represents a key ingredient in the preparation of daily meals among the 
general population (Al-Habori and Raman, 2002). 
Fenugreek also has been used for over two thousand years as a medicinal plant in 
various parts of the world (Srinivasan, 2006) and may be regarded as the oldest medicinal 
plant in human history (Lust, 1986 cited in Petropoulos, 2002). As a medicinal plant, use 
of fenugreek is associated with a wide range of therapeutic applications including  its use 
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as a carminative (prevents flatulence) to its use as an aphrodisiac (Chopra et al., 1982). 
Reference to fenugreek has been made in Indian Ayurvedic and Traditional Chinese 
Medicines where it is recognized as a galactogogue or lactation stimulant in women after 
child birth as well as for its ability to treat wounds and sore muscles (Tiran, 2003). In 
addition, some plants also possess antibacterial (Thomas et al., 2006), anti-ulcer (Al-
Meshal et al., 1985), anti-cancer (Shishodia and Aggarwal, 2006), anthelmintic 
(antagonistic effect against parasitic worms) (Ghafghazi et al., 1977), and anti-
nociceptive (pain-reducing) properties (Javan et al., 1997).   
In recent years, laboratory studies and clinical trials have focused on fenugreek as 
a potential nutraceutical. These studies have shown that fenugreek plants possess 
immunomodulatory (Bin-Hafeez et al., 2003), hypocholesterolaemic (Sharma, 1986a; 
Evans et al., 1992; Stark and Madar, 1993), hypoglycaemic (Khosla et al., 1995; Vats et 
al., 2002), gastro- and hepatoprotective (Pandian et al., 2002; Thirunavukkarasu et al., 
2003) and antioxidative (Anuradha and Ravikumar, 2001; Choudhary et al., 2001) 
properties. Pharmacological properties of fenugreek have been explored to identify a role 
for the plant in diabetes management (Sharma et al., 1996a, 1996c; Puri et al., 2002) and 
in cardiovascular health (Petit et al., 1995b; Sauvaire et al., 1996; Hannan et al., 2003), 
indicating the presence of bioactive compounds in fenugreek, which may be responsible 
for its health benefits. 
 Fenugreek has been commercially grown in western Canada since around 1992, 
shortly after the first Canadian cultivar “AC Amber” was released by the Agriculture and 
Agri-Food Canada (AAFC) Research Centre in, Morden, Manitoba. This was followed 
by the release of “CDC Quatro” by the Crop Development Centre (CDC) Saskatoon, 
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Saskatchewan (Slinkard et al., 2006).  In 2002, CDC Canafen (used as a source of 
galactomannan) and CDC Canagreen (used for forage purposes) were released by the 
CDC in Saskatoon, and these two cultivars are licensed exclusively to Emerald Seeds 
Products Limited in Avonlea, Saskatchewan, Canada (Slinkard et al., 2006; Blaine 
Sudom, personal communication, 2008). Fenugreek also was grown in southern Alberta 
first for seed as a source for spice, but later as a forage crop. The fenugreek crop 
improvement programs conducted at both the provincial [Alberta Agriculture and Rural 
Development (ARD), Crop Diversification Centre South (CDCS), Brooks] and federal 
(AAFC Lethbridge Research Centre) research institutions have selected genotypes based 
mainly upon high seed and/ or forage yield and early maturity traits, and in 2004, the 
Lethbridge Research Centre released “Tristar” as the first registered North American 
forage cultivar.  
 Accumulated experimental evidence and human trials has supported many of the 
health, medically related and nutraceutical claims made for fenugreek (Acharya et al., 
2007b). This has led to a growing interest in marketing of fenugreek as a natural health 
product. However, limited information is available regarding the biochemical 
composition of the genotypes that are being used in these health related applications, 
raising concern over the ability of the plant to produce desired results (Taylor et al., 
2002; Acharya et al., 2004; Thomas et al., 2006). Key bioactive compounds found in 
fenugreek need to be quantified in order to ensure that the plants being used possess the 
bioactive compounds essential to produce the desired effects in consumers. Once plants 
with these attributes have been identified, they can be used for selection of suitable 
                                                 
 Blaine Sudom, Chief Operating Officer, Emerald Seeds Products Limited, Avonlea, 
Saskatchewan, Canada (www.emeraldseedproducts.com). 
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genotypes that can be further developed into cultivars specific for the natural health 
product processing industry.  
 Three putative bioactive compounds were examined in these experiments; i.e., 
galactomannan, diosgenin [(25R)-spirost-5-en-3--ol] and 4-hydroxyisoleucine. These 
compounds are among the most frequently identified in the literature for their medicinal 
and health attributes (Acharya et al., 2007b). However, there are many unknown factors 
associated with genotype optimization and crop growing environments in relation to the 
productivity of bioactive compounds in fenugreek.    
 
Objectives of this research study project were to: 
 
i. Determine the content and productivity of selected bioactive compounds 
(galactomannan, diosgenin and 4-hydroxyisoleucine), and seed yield of ten most 
promising fenugreek genotypes that have been previously selected based on seed 
and/or biomass yield and early maturity under the growing conditions in southern 
Alberta. 
ii. Assess the impact of growing environment on content and productivity of the three 
bioactive compounds and seed yield of ten fenugreek genotypes. 
iii. Identify the most promising fenugreek genotypes, based on production, productivity 
and production stability of these selected bioactive compounds, under growing 
conditions (rainfed and partially irrigated) in southern Alberta. 
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Figure 1.1  Foliage (A), pod(s); field-growing (B) and harvested (C), and color and 
seed size variation of harvested seeds (D) of the fenugreek plant. 
 
 
      
 4 rows spaced 30 cm apart 
 Each block spaced 60 cm apart 
1.6 cm 
(D)
(A) 
(C)
(B) 
2.3 cm 
60 cm 30 cm 
Fenugreek pods can range from 10 – 15 cm in 
length 
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2.0 Literature review 
 
2.1 Taxonomy of fenugreek 
  Fenugreek (Trigonella foenum-graecum) is an annual, self-pollinating legume. 
Most plants are diploid (2n=16) and often used as crops in agriculture (Petropoulos, 
2002).  Sinskaya (1961), Hutchinson (1964) and Heywood (1967), all have described 
plants belonging to the genus Trigonella. In general, the plants are scented and can be 
collectively categorized according to their distinct botanical characteristics (Table 2.1).  
  Taxonomy of the plant is as follows: 
 Kingdom Plantae 
 Class  Magnoliopsida 
 Order   Fabales 
 Family  Fabaceae 
 Genus  Trigonella 
   Species     foenum-graecum 
 
2.2 Botanical and physiological aspects of fenugreek 
Germinated seeds from fenugreek form a seedling, which eventually develops into 
stems, flowers, pods and seeds (Petropoulos, 2002). Following swelling of the seed, the 
radicle emerges from the seed coat, penetrates the soil and initiates primary root 
development. Release of cotyledons from seed husks soon follows and leads to growth of  
 7 
 
Table 2.1 Characteristics of plants of the genus Trigonella. 
Plant organs/tissues Characteristics 
Leaves Trifoliate, usually toothed, nerves 
running out into teeth 
Flowers 
  
 Calyx 
 Corolla 
 Anthers 
 Stigma 
 Ovary 
Solitary, pedunculate in axillary 
heads 
Teeth may be equal or unequal 
Yellow, blue or purple 
Uniform 
Terminal 
  Sessile, ovules are numerous 
Pods 
 
 
 
Cylindrical or compressed, linear or 
oblong, indehiscent or dehiscing 
with a pronounced beak 
Seeds Tuberculate , cotyledons geniculate 
Source: Petropoulos (2002) 
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 the first simple leaf, followed by development of the first trifoliate leaf (Petropoulos, 
2002). Throughout the plant, the leaves are found in an alternate arrangement, are ovate 
in appearance and slightly toothed (Slinkard et al., 2006). Stems of the mature fenugreek 
plant are circular to slightly quadrangular, with a diameter of 0.5 - 1.0 cm. They are erect, 
hollow and may appear green or pinkish-green due to accumulation of anthocyanin 
(Petropoulos and Koulombis, 2002).   
Flowering of fenugreek starts approximately 35-40 days from the date of sowing, 
and varies according to plant variety, climate and season in which the seeds were sowed  
(Petropoulos, 2002). The flowers sit in the leaf axils, are generally paired, but 
occasionally are solitary. There are two types of flower shoots; one that bears axillary 
flowers and follows an indeterminate growth habit and the other, referred to as ‘blind 
shoots’ that can carry both axillary and terminal flowers which eventually become tip 
bearers.  There are two kinds of flowers; cleistogamous (closed) flowers and 
aneictogamous (open) flowers. Closed flowers are found on most plants. The keel of 
these plants remains closed throughout the flower’s life, favoring self-pollination. Open 
flowers, in contrast, offer an abundance of opportunities for cross-pollination, as the 
corolla remains open continuously. However, these represent less than 1 % of fenugreek 
flowers (Petropoulos, 2002). 
Seed pods from fenugreek plants are long, slender, sickle-shaped and pointed 
(with a sharp beak at the end). They appear brownish or yellowish brown and can be 10-
19 cm in length and 0.2-0.6 cm in width (Ivimey-Cook, 1968 and Duke, 1986 cited in 
Petropoulos, 2002). Fenugreek plants can be single- (one pod per node) or double-podded 
(two pods per node projecting in opposite directions). Double-podded varieties appear to 
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contain higher levels of bioactive compounds (i.e. diosgenin; Petropoulos, 2002). Each 
seed-bearing branch of the plant can produce about 2-8 pods, each carrying roughly 10-
20 seeds (Petropoulos and Koulombis, 2002). Fenugreek seeds are surrounded by a seed 
coat (testa), which is separated from the embryo by the endosperm, the principal storage 
organ in the seed (Spyropoulos, 2002).  Between the seed coat and the endosperm, lies a 
single-cell layer of living tissue known as the aleurone layer. Galactomannan, a long 
chain polysaccharide makes up a large portion of the stored reserves in the seed, and is 
deposited as a cell wall thickening on the surface of cells in the endosperm. Deposition of 
galactomannan also occurs at the outer walls of the aleurone layer neighboring the seed 
coat (Spyropoulos, 2002). Seeds are generally about 3-6 mm long, 2-4 mm wide and 2 
mm thick (Fazli and Hardman, 1968 cited in Petropoulos, 2002). The seeds have a 
rectangular or rhomboidal shape with grooves between the radicle and the cotyledon. 
They are generally yellowish-brown to golden yellow, but new cultivars that lack 
polyphenolic tannins, appear pale yellowish-white.  The weight of a thousand seeds, a 
common seed quality determinant averages around 15-20 g (Slinkard et al., 2006).   
 
2.3  Historical uses of fenugreek 
 Fenugreek is one of the oldest known medicinal plants that have been documented 
in ancient herbal publications, religious scriptures, travel records and anecdotes dating 
back in human history (Lust, 1986 cited in Petropoulos, 2002). Seeds of the fenugreek 
plant were found in the tomb of the Egyptian Pharaoh, Tuthankhamun (1333 BC – 1324 
BC) and leaves of the fenugreek plant were used as one of the components of holy smoke 
that the Egyptians used in fumigation and embalming rites (Fazli and Hardman, 1968 
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cited in Petropoulos, 2002). During the ancient Greek period, fenugreek was cultivated as 
a forage crop. In ancient Rome, it was used as an aid to induce labor during childbirth 
and delivery (Yoshikawa et al., 1997). Utilization of fenugreek in Chinese medicine was 
first introduced during the Song Dynasty (AD 1057). It was used in traditional Chinese 
medicine as a tonic and treatment for weakness and edema (tissue swelling due to excess 
lymph fluid) of the legs (Basch et al., 2003). Fenugreek was later introduced to Central 
Europe at the beginning of the 9th century but it was not until the 16th century when 
cultivation of the plant in England was recorded (Petropoulos, 2002).  
 
2.4  Modern uses of fenugreek 
 One of the major uses of fenugreek seeds and leaves is for medicinal purposes. In 
India (Basch et al., 2003) it has been used as part of traditional medicine practices. 
Fenugreek contains a myriad of phytochemicals such as steroids, flavonoids and alkaloids, 
which have been identified, isolated and extracted by the pharmaceutical industry to 
serve as raw materials for the manufacture of hormonal and therapeutic drugs 
(Petropoulos, 2002). Polysaccharides form the mucilage (galactomannan) present in the 
plant, and are finding wider applications in the food, pharmaceutical, cosmetics, paint and 
paper industries (Petropoulos, 2002) following the more commonly used locust bean and 
guar gums, all of which possess high viscosity and neutral ionic properties (Duke, 1986 
cited in Petropoulos, 2002). However, fenugreek seed is most commonly used in 
everyday life as a spice and a seasoning in soups and curries (Duke, 1986 cited in 
Petropoulos, 2002). In India, fenugreek is consumed as a condiment, and is used as a 
coloring dye and as a medicinal stimulant to promote lactation in post-partum women and 
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animals (Fazli and Hardman, 1968 cited in Petropoulos, 2002; Basch et al., 2003). 
Another alkaloid, trigonelline that has been extracted from fenugreek contributes to its 
distinctive odor. Trigonelline can be used in the manufacture of imitation maple syrup 
and artificial flavoring for licorice, vanilla, rum and butterscotch (Slinkard et al., 2006).  
 
2.5 Fenugreek oils 
Extractable oil from fenugreek represents about 6-8% of the seed weight and 
carries a fetid odor and bitter taste. Its fatty acid composition is listed in Table 2.2 
(Sulieman et al., 2008). It is reported that the unsaponifiable portion of the oil (3.9 %) 
contains a lactation-stimulation factor (Srinivasan, 2006). Being strongly scented, the oil 
is used as an insect repellent for grains and cloths (Duke, 1986 cited in Petropoulos, 
2002). In cosmetics, traces of the oil are used in perfumes (Fazli and Hardman, 1968 
cited in Petropoulos, 2002). 
 
2.6   Fenugreek as a forage crop 
The high forage value of fenugreek is attributed to its rich content of protein, 
vitamins, and amino acids along with its good digestibility in cattle. The seeds contain 
diosgenin, a growth and reproduction hormone. The combination of the above factors in 
fenugreek is thought to improve growth rates and feed utilization efficiency in beef cattle 
[Alberta Agriculture and Rural Development, 2007]. In a study by Shah and Mir (2004), 
20 % (w/w) fenugreek seed was supplemented into a dairy cattle diet and was reported to 
significantly improve the fatty acid profile in the milk produced ; an increase in the  
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Table 2.2 Fatty acid composition of oil extracted from fenugreek seeds.
Fatty acid Content (%) 
Palmitic acid 11.0 
Stearic acid 4.5 
Arachidic acid 1.5 
Oleic acid 16.7 
Linoleic acid 43.2 
α-Linolenic acid 22.0 
   Source: Sulieman et al. (2008) 
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 polyunsaturated fatty acid (i.e. linoleic, linolenic and conjugated linolenic acids) 
concentrations was observed. The study also found that the fenugreek-fed cattle had a 4 
% reduction in blood cholesterol concentration as well as a 19 % decrease in milk 
cholesterol levels compared to controls, potentially extending health benefits to human 
consumers of the milk. 
 
2.7 Fenugreek as a functional food 
  Presence of galactomannan in fenugreek seed accounts for approximately half of its 
dry weight and is recognized as the principal source of soluble dietary fiber in the plant 
(AAFC, 2005). Dietary fiber is known to have the potential to reduce risk of 
cardiovascular disease and to protect against some cancers through the reduction of low-
density lipoprotein (LDL) and total cholesterol (AAFC, 2005). In Egypt, supplementation 
of wheat flour with a small percentage of fenugreek flour has been reported to enhance 
the nutritional quality of bread as well as its organoleptic characteristics (Bakr, 1997). 
Addition of fenugreek flour to more commonly used flours for bread making is a 
common practice in Egypt (Galal, 2001). Sharma and Chauhan (2000) reported improved 
physicochemical, nutritional and rheological properties of bread made from wheat flour 
supplemented with fenugreek flour. Galactomannan (mucilage or gum) in fenugreek acts 
as a thickener or stabilizer in foods such as soups, sauces and ice-cream (Garti et al., 
1997, Balyan et al., 2001, Seghal  et al., 2002). Currently, the food industry utilizes 
locust bean gum and guar gum as emulsifiers, viscosity-builders, thickeners and 
stabilizers. The relatively low cost and ease of growing fenugreek in abundance in 
Canada makes fenugreek gum a potential candidate for commercial use.  
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2.8  Distribution and cultivation of fenugreek  
   Fenugreek is native to the Indian subcontinent and the Eastern Mediterranean 
region. However, it also has been grown in central Asia and in North Africa since early 
times (Petropoulos, 2002). The extent to which fenugreek has been distributed throughout 
the world is indicated by the various names it assumes in different countries (Srinivasan, 
2005); i.e., Fenugrec (French), Methi (Hindi), Bockshorklee (German), Fieno greco 
(Italian), Pazhitnik (Russian), Alholva (Spanish), Koroha/Koroba  (Japanese), Hulba 
(Arabic), Halba (Malaya), and Ku’-Tou / Hu Lu Ba (Chinese). Other local names for 
fenugreek in different regions are given in Table 2.3 (Petropoulos, 2002). Fenugreek has 
been reported as a cultivated crop in all habitable continents of the world. A breakdown 
of the various countries of each continent that cultivates fenugreek as a crop is listed in 
Table 2.4. 
 
2.9 The fenugreek market 
  Estimates show that the annually cultivated area of fenugreek is about 57 000 ha, 
with seed production at 68 000 tons (Petropoulos, 2002). Currently, fenugreek represents 
an important cash crop in India (the leading producer), Morocco, China, Pakistan, Turkey, 
Egypt and Ethiopia (Fotopoulos, 2002). India claims to produce 70-80 % of the world’s 
exported fenugreek, followed by Morocco (Fotopoulos, 2002). Other exporting countries 
include Spain, which supplies major markets in Italy, Tunisia, Turkey, Lebanon and 
Israel. The major export market for Indian fenugreek appears to be European Union, 
Japan, United Arab Emirates, Yemen and South Africa (Weiss, 2002). 
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Table 2.3 Local names for fenugreek in different countries. 
Language Local names for fenugreek 
Arabic 
Armenian 
Azerbaijani 
Chinese 
Croatic 
Czech 
Dutch 
Ethiopian 
French 
German 
 
Greek (modern) 
 
Hindi 
Hungarian 
Italian 
Japanese 
Malay 
Persian  (Irani) 
Polish 
Portuguese 
Slovak 
Spanish 
Swedish 
Russian 
Uzbekistani 
Hulba, Hulabah, Hhelbah, Hhelbeh 
Shambala 
Khil’be, Boil 
Ku’-Tou, Hu Lu Ba 
Piskayika, ditelina rogata 
Piskayika, recke seno 
Fenegriek 
Abish 
Fenugrec 
Bockshorklee, Griechisch Heu, Griechisches 
Heu, Kuhhornklee, Bisamklee 
Trigoniskos, Tsimeni, Tintelis, Moschositaro, 
tili, tilipina 
Methi 
Görögszéna 
Fieno greco 
Koroha , Koroba 
Halba 
Schemlit 
Fengrek, Kozieradka 
Alforva 
Seneyka grecka, seno grecka 
Alholya 
Bockhornsklover 
Pazhitnik 
Khul’ba, Ul’ba, Boidana 
Source: Petropoulos (2002) 
 
Table 2.4 Cultivation and distribution of fenugreek in the world. 
Continent Country 
Asia 
 
Africa 
 
Europe 
 
 
North America  
South America 
Australia/Oceania 
China, India, Iran, Israel, Japan, Lebanon, 
Pakistan  
Egypt, Ethiopia, Kenya, Morocco, Sudan, 
Tanzania, Tunisia  
Austria, England, France, Germany, Greece, 
Portugal, Russia, Spain, Switzerland, Turkey, 
Ukraine, United Kingdom 
Canada, the United States 
Argentina 
Southwestern and southeastern Australia 
Source: Petropoulos (2002) 
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 Major importing countries are generally European nations with Germany as the 
largest importer of fenugreek from India, Morocco and China. Germany roughly imports 
close to 200 tons of seed annually, mainly using it to flavor food (Fotopoulos, 2002). 
France, Holland, Spain and the United Kingdom follow closely as major importers of the 
spice in Europe. 
 In North America, fenugreek is relatively unfamiliar to most households. 
However, there is interest among forage breeders to market fenugreek as a potential 
animal feed (Shah and Mir, 2004). There is also significant development in the 
nutraceutical industry in which fenugreek is used as a source of bioactive components for 
health supplements (TSI Health Sciences, Emerald Seed Products). 
 
2.10  Fenugreek in Canada 
     Fenugreek was introduced into Canada as a spice and forage crop. The first 
commercial cultivar AC Amber was released by the AAFC Research Station at Morden, 
Manitoba. Shortly after its release, commercial growth of fenugreek was initiated in 
western Canada. Other cultivars released include CDC Quatro, CDC Canagreen and CDC 
Canafen, all developed at the Crop Development Centre (CDC), University of 
Saskatchewan, Saskatoon. Tristar, developed primarily as a forage cultivar by AAFC at 
Lethbridge, Alberta in cooperation with Alberta Agriculture and Rural Development was 
released in 2004. Currently, more than 700 acres of land in western Canada are dedicated 
to the planting of fenugreek for seed production, much of which is concentrated in 
                                                 
 TSI Heath Sciences is a US-based nutraceutical company that was recently awarded a 
patent (March 2008) to produce a fenugreek seed extract containing 4-hydroxyisoleucine 
in its manufacture of Promilin, a health supplement (www.tsiinc.com). 
 17 
 
southern Saskatchewan (Blaine Sudom, personal communication, 2008). Emerald Seed 
Products, a Saskatchewan-based functional food and plant-based natural products 
manufacturer utilize fenugreek seeds as a source of galactomannan and diosgenin for the 
natural health products and feed industries, respectively. CDC Canagreen (primarily 
developed for forage use) and CDC Canafen are licensed exclusively to this organization 
for these purposes (Blaine Sudom, personal communication, 2008). Emerald Seeds 
Products is also currently the sole producer of fenugreek extracts as natural health 
products in Canada. Fenugreek seeds produced in southern Saskatchewan are also sold to 
producers in Alberta and Manitoba for forage production (Blaine Sudom, personal 
communication, 2008). 
 
 
2.11  Chemical constituents in fenugreek 
   Fenugreek seed contains approximately 4 - 10 % moisture, 6 - 8 % fat, 18 - 30 % 
protein and 48 - 55 % fiber (Sauvaire et al., 1976; Sharma et al., 1986b; Vats et al., 2003; 
Srinivasan, 2006), depending on varietal and ecological factors. A comprehensive list of 
chemical components found in fenugreek leaves and seed is provided in Table 2.5.  
Hemavathy and Prabhakar (1989) published a detailed report on the lipid 
composition of fenugreek seeds. In their report, total lipids extracted from dry seeds were 
7.5 %, which agrees with other values given in the literature (Srinivasan, 2006). 
Fractionation of the lipids extracted indicates that the seed contains 84.1 % neutral lipids 
(composed mainly of triacylglycerols), 5.4 % glycolipids and 10.5 % phospholipids. A  
                                                 
 Blaine Sudom, Chief Operating Officer, Emerald Seed Products Limited, Avonlea, 
Saskatchewan, Canada (www.emeraldseedproducts.com) 
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Table 2.5 Chemical composition of fresh fenugreek leaves and mature seeds. 
Component Fresh fenugreek 
leaves (100 g) 
Fenugreek seeds 
(100 g) 
Moisture 86.0 g
Protein 4.4 g 30 g
Fat 1.0 g 7.5 g
Fiber 1.0 g 50 g
Sapogenins 
  Diosgenin 
  Yamogenin 
  Gitogenin 
  Neogitogenin 
  Yuccagenin 
  Tigogenin 
  Sarsasapogenin 
  Smilagenin 
2 g
Trigonelline 380 mg
Ca 395 mg 160 mg
Mg 67 mg 160 mg
P 51 mg 370 mg
Fe 16.5 mg 14 mg
Na 76 mg 19 mg
K 31 mg 530 mg
Cu 0.26 mg 33 mg
S 167 mg 16 mg
Cl 165 mg 165 mg
Mn 1.5 g
Zn 7.0 mg
Cr 0.1 mg
Choline 1.35 g 50 mg
Vitamin C 52 mg 50 mg
Β-carotene 2.3 mg 96 µg
Thiamine 40 µg 340 µg
Riboflavin 310 µg 290 µg
Nicotinic acid 800 µg 1.1 mg
Folic acid 84 µg
Source: Srinivasan (2006) 
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breakdown of the fatty acid composition shows that linoleic acid is the predominant fatty 
acid, followed by α-linolenic acid and oleic acid. 
   Some of the biological and pharmacological attributes of fenugreek are ascribed 
to the abundance of chemical constituents it contains; i.e., its steroids (saponins/ 
sapogenins), alkaloids, polyphenolic compounds, volatile compounds and amino acids, in 
particular 4-hydroxyisoleucine (Skaltsa, 2002; Srinivasan, 2006). 
 The bitter flavor of fenugreek is most likely due to the presence of saponins  
(4 -8 %) and alkaloids (~ 1 %). Consumption of these constituents appears to contribute 
to gastric stimulation, increased acidity and improved appetite (Srinivasan, 2006).  
 
2.11.1  Steroids 
Fenugreek contains various steroidal sapogenins with diosgenin (∆5, 25α-
spirostan-3β -ol) being the major component. Sapogenins are the aglycone portions of the 
of plant-based steroid-derivative saponins, containing 6-C rings with 2 to 3 side chains 
substitutable either with methyl or hydroxyl groups (Skaltsa, 2002). Saponins are 
amphipatic glycosides (Fig. 2.1), containing both hydrophilic glycoside and lipophilic 
triterpene moieties, therefore capable of producing soap-like foaming properties.  
Diosgenin, a 27-C steroidal compound (Fig. 2.2) is currently used as a raw 
material for the manufacture of oral contraceptives and sex hormones by the 
pharmaceutical industry (Skaltsa, 2002). It is traditionally extracted from wild Mexican 
and Asian yam species, Dioscorea. Utilization of fenugreek seeds as an alternative source 
of diosgenin was proposed in the 1950s in recognition of the increasing demand for raw 
steroids (Marker et al., 1947 and Fazli and Hardman, 1968 cited in Skaltsa, 2002;  
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Figure 2.1 Chemical structure of solanine, exemplifying the amphipathic properties 
of a typical steroidal saponin. 
  
 
 
 
 
Figure 2.2 Chemical structures of diosgenin (A) and yamogenin (B) showing 
epimerism at C-25. Source: Pires et al. (2002). 
(A) (B) 
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Bhatnagar et al., 1975). It is important to note that fenugreek seeds contain no free 
sapogenins (Sauvaire and Baccou, 1978), and that they occur as complex glycosides 
(saponins) which are released following enzymatic treatment or acid hydrolysis (Blunden 
and Hardman, 1963 cited in Skaltsa, 2002). Fenugreek sapogenins also occur in various 
forms due to stereochemistry and functional groups substititution. Those that have been 
reported in extracts from fenugreek seeds are diosgenin, yamogenin, tigogenin, 
neotigogenin, yuccagenin, lilagenin, gitogenin, neogitogenin, sarsapogenin and 
smilagenin (Gupta et al., 1986b; Cornish et al., 1983; Skaltsa, 2002). Yamogenin is the 
(25S)-epimer of diosgenin (Fig. 2.2) and occurs at a ratio of 2:3 with diosgenin in the 
seed, acid-hydrolyzed extract (Skaltsa, 2002)  
 
2.11.2 Polyphenolic compounds 
Polyphenols possess anti-oxidative attributes, which may prevent some forms of 
chronic disease. Gupta and Nair (1999) reported that fenugreek is generally rich in 
polyphenols (100 mg g-1). The phenylpropanoid pathway occurs ubiquitously across the 
plant kingdom and has been shown to be involved in the biosynthesis of important 
secondary plant metabolites such as flavonoids and lignins (Dixon and Sumner, 2003).             
 Flavonoids consist of several classes; i.e., the flavones, flavonones, flavonols, 
flavanols (flavan-3-ols), isoflavones, proanthocyanidins and anthocyanins. They exhibit 
strong antioxidative effects in vitro and have been largely associated with prevention of 
oxidative damage in biological systems, which can confer protection against 
cardiovascular disease and cancer (Erdman et al., 2005). Flavonoids have a basic three 
ring chemical structure; i.e., two aromatic rings (A and B) coupled with a three-carbon 
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oxygenated heterocyclic ring (C) (Fig. 2.3). Among the many flavonoids reported in 
fenugreek, quercetin, luteolin, vitexin and kaempferol appear to be the most common 
(Parmar et al., 1982; Jain et al., 1992; Huang and Liang, 2000; Skaltsa, 2002). Quercetin 
and kaempferol are flavonols (Fig. 2.4); luteolin is a flavone (Fig. 2.5) while vitexin 
occurs as a glycosylated flavone (Fig. 2.6).  
Isoflavanoid phytoalexins are also reported to occur in fenugreek in the form 
of the pterocarpans, medicarpin (Fig. 2.7) and maackiaian (Ingham, 1981). These 
compounds play a key role in maintaining plant health in the event of microbial invasion; 
they are absent in healthy plants and their production is only induced upon microbial 
attack (Skaltsa, 2002). 
Polyphenolics are also potent antioxidants that scavenge for free radicals and 
protect against oxidation. Common phenolic compounds isolated from fenugreek are 
scopoletin, coumarin, chlorogenic and caffeic and p-coumaric acids (Figs. 2.8 and 2.9) 
(Skaltsa, 2002; Acharya et al., 2007b). Aqueous extracts of germinated fenugreek seeds 
containing 17.5 mg mL-1 quercetin and 64.4 mg mL-1 gallic acid equivalents per gram of 
fenugreek powder and was shown to exhibit significant antioxidant activity and offered 
greater protection against oxidation compared to other extracts (Dixit et al., 2005). 
The protective action of fenugreek seed polyphenols has been investigated in 
rats on lipid peroxidation using aqueous extracts and was found to exert gastroprotective 
effect on gastric ulcer (Pandian et al., 2002) and prevent ethanol-induced toxicity in the 
liver and the brain (Thirunavukkarasu et al., 2003). Recently, Kaviarasan et al. (2006) 
reported on the cytoprotective effect of a polyphenolic extract of fenugreek seeds against 
ethanol-induced damage in human Chang liver cells. The protective effects were found 
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Figure 2.3 Basic chemical structure of a flavonoid. 
 
 
 
 
Figure 2.4 Chemical structure of a flavonol; quercetin when R1 = OH, R2 = H; 
kaempferol when both R1 and R2 = H. Source: Dubber and Kanfer (2004). 
 
 
 
Figure 2.5 Chemical structure of luteolin, a flavone. 
 
 
 
 
Figure 2.6 Chemical structure of vitexin (8-C--D-glucosyl 5, 7, 4'-
trihydroxyflavone). Source: chemBlink (2008). 
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Figure 2.7 Chemical structure of the pterocarpan, medicarpin. Source: European 
Bioinformatics Institute (2008). 
 
 
 
                   
 
 
 
Figure 2.8 Chemical structures of (A) scopoletin and (B) coumarin. 
 
 
 
        
 
 
 
Figure 2.9 Chemical structures of (C) chlorogenic acid, (D) caffeic acid and (E) 
p-coumaric acid. 
(A) (B) 
(C) 
(D) 
(E) 
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comparable to a silymarin, a known hepatoprotective agent.  
 
2.11.3   Alkaloids 
     Trigonelline (Fig. 2.10), a methylbetaine derivative of nicotinic acid (Skaltsa, 
2002) is one of the major alkaloids found in fenugreek seeds. This compound (chemical 
formula C7H7NO2) has been reported to exert mild hypoglycemic (Shani et al., 1974; 
Marles and Farnworth, 1994) and anti-pellagra [pellagra is a disease caused by lack of 
dietary niacin (vitamin B3) and the amino acid tryptophan] effects (Bever and Zahnd, 
1979).  
 
2.11.4    Volatile components 
           Volatile constituents contribute to the aroma and flavor of fenugreek. Anethol 
(Fig. 2.11), an aromatic compound found mostly in anise, camphor and fennel, also 
occurs in fenugreek and produces a licorice-like aroma (Aggarwal and Shishodia, 2006; 
Acharya et al., 2007b). Mazza et al. (2002) have identified 175 volatile constituents in 
Sicilian fenugreek seeds, which include carbonyls, sesquiterpene hydrocarbons, alcohols, 
heterocyclic, and furan compounds. Sotolone (3-hydroxy-4,5-dimethyl-2(5H)-furanone 
(Fig. 2.12) has been identified as the principal component contributing to the flavor of 
fenugreek (Hatanaka, 1992; Blank et al., 1997). These compounds together impart the 
burnt sugar, curry or maple syrup flavour, which is characteristic of fenugreek (Monastiri 
et al., 1997). 
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Figure 2.10 Chemical structure of trigonelline. 
 
 
 
 
 
Figure 2.11 Chemical structure of anethol. 
 
 
 
 
 
Figure 2.12 Chemical structure of sotolone, the principal flavour constituent in 
fenugreek. 
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2.12 Bioactive Compounds and their Biochemistry 
      Various clinical (Bhardwaj et al., 1994; Sharma et al., 1996a; Vajifder et al., 
2000; Sowmya and Rajyalakshmi, 1999; Abdel-Barry et al., 2000; Gupta et al., 2001) 
and animal studies (Sauvaire et al., 1991; Evans et al., 1992; Thirunavukkarasu et al., 
2003; Anuradha and Ravikumar, 2001; Puri et al., 2002; McAnuff et al., 2002) conducted 
using fenugreek have identified numerous potential health benefits for consumption of 
fenugreek, and have drawn much attention to fenugreek as a potential functional food and 
natural health product or ingredient therein. Among the plethora of bioactive compounds 
found in fenugreek, the three major chemical constituents, galactomannan, diosgenin and  
4-hydroxyisoleucine have, by far superseded the rest as being the most frequently studied 
health-promoting factors for humans. 
 
2.12.1 Galactomannan 
 Galactomannan (Fig. 2.13) represents the major polysaccharide found in 
fenugreek seeds and accounts for approximately 17 – 50 % of the dry seed weight 
(Petropoulos, 1973 and Duke, 1986 cited in Petropoulos, 2002; Kochhar et al., 2006). It 
is an integral component of the cell wall which is found concentrated around the seed 
coat (Spyropoulos, 2002). Galactomannans are structurally composed of a 14 beta-D-
mannosyl backbone substituted by a single galactose unit α-linked at the C-6 oxygen 
(Bhaumick, 2006). Fenugreek galactomannans are unique relative to other commonly 
used galactomannans such as those found in guar and locust beans. They contain a 
galactose to mannose ratio of 1:1. This high degree of galactose substitution renders the 
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Figure 2.13 Chemical structure of fenugreek galactomannan (adapted from 
Bhaumick, 2006) 
  
n
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molecule relatively more soluble compared to galactomannans from guar or locust bean, 
which has a galactose to mannose ratio of 1:2 and 1:4, respectively (Reid and Meier, 
1970; Brummer et al., 2003). 
 Enzyme specificity was shown to influence the degree of galactose 
substitution during galactomannan formation. It has been shown that substitution 
on the mannan backbone is determined by the existing galactose-substitution pattern 
on to the nearest mannosyl residues (Reid et al., 2003). Biosynthesis of galactomannan is 
attributed to the cooperative actions of both D-mannosyltransferase and D-
galactosyltransferase. Mannosyltransferase was shown to require divalent metal cations 
such as Ca2+, Mg2+ and Mn2+ for its activity, whereas galactosyltransferase has a specific 
requirement for Mn2+. 
The formation of (14) β-linked mannan by D-mannosyltransferase is independent of 
the presence of UDP-D-galactose, while the activity of D-galactosyltransferase is highly 
dependent on the transfer of D-mannosyl residues from GDP-D-mannose. 
Mannosyltransferase extends the linear (14)-β-linked D-mannan backbone towards the 
non-reducing terminus, while galactosyltransferase transfers a (16)-α-D-galactosyl 
residue onto the growing mannan chain from the same end. 
  The soluble nature of galactomannan fiber from fenugreek has been linked to 
numerous human health benefits, mainly in the reduction of plasma glucose levels which 
has an antidiabetic effect (Sharma 1986b; Madar et al., 1988; Madar and Shomer, 1990). 
This has been demonstrated in animal models where diabetes was experimentally induced 
in dogs, rats, mice and rabbits using either alloxan or streptozocin (Zanosar®) which kill 
insulin-producing beta cells in the pancreas of mammals (Ribes et al., 1986; Swanston-
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Flatt et al., 1989; Grover et al., 2002; Mondal et al., 2004; Hannan et al., 2007).Hannan 
et al. (2007) also have demonstrated that the soluble dietary fiber (SDF) portion of 
fenugreek can significantly improve glucose homeostasis in type 1 and type 2 diabetes by 
delaying carbohydrate digestion and absorption. They have also suggested that the SDF 
fraction may enhance insulin action in type 2 diabetes as indicated by the improvement of 
oral glucose tolerance in these test subjects. 
  Monnier et al. (1978) and Jenkins (1979) reported that addition of soluble fiber 
to the diet of diabetics reduced blood glucose during an oral glucose tolerance test 
(OGTT).  The OGTT is a blood test that is used to assess metabolism of sugar in test 
subjects. Individuals are required to fast prior to consuming a fixed amount of glucose. 
Their blood is later tested at designated time intervals in order to determine if it will reach 
unusually high glucose levels (American Diabetes Association, 2008). Johnson and Gee 
(1980) reported that use of soluble fiber from fenugreek resulted in inhibition of glucose 
absorption in the intestine. It has been postulated that fenugreek galactomannan may 
regulate plasma glucose levels by delaying gastric emptying and by interfering with 
glucose absorption in the gut (Madar, 1984; Al-Habori and Rahman, 1998; Nahar et al., 
2000).  Sharma (1986b) suggested that the delay in carbohydrate absorption induced by a 
diet rich in fenugreek fiber could reduce insulin requirements. Dietary fibers such as 
galactomannan are able to reduce postprandial glycaemia and exhibit great potential in 
diabetes management (Jenkins et al., 2000; Basch et al., 2003). 
  In several small-scale clinical trials, fenugreek seeds have been found to reduce 
fasting serum glucose levels in patients exhibiting both acute and chronic hyperglycaemia 
(Basch et al., 2003). Cooked and defatted fenugreek seeds (containing soluble fiber) 
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prevented a rise in blood glucose levels in these patients. This was attributed to 
hypoglycaemic properties of fenugreek gum present in the seeds which were not lost 
during the cooking process (Srinivasan, 2006). Sharma et al. (1990) and Sharma and 
Raghuram (1990) also have reported that reduced levels of fasting blood glucose, 
improved glucose tolerance and reduced glucose excretion in both insulin-dependent 
(type 1) diabetic and  non-insulin dependent (type 2) diabetic patients respectively, 
following a 10-day trial in which the subjects were given 100 g of defatted fenugreek 
powder. Pahwa (1990) conducted a study using both diabetic and non-diabetic test 
subjects and reported a significant hypoglycaemic effect only in diabetic individuals 
following fenugreek consumption prior to glucose loading (1 g kg-1 body weight). 
However, in a later study by Nahar et al. (1992), a similar blood glucose lowering effect 
was observed in healthy human subjects given the soluble fiber fraction as a single dose. 
A double-blind, placebo-controlled study involving 25 type 2 diabetic patients was 
conducted by Gupta et al. (2001) to evaluate the effects of fenugreek on control of blood 
glucose levels and insulin resistance. Diabetic and normal patients were separated into 
groups, and they received an alcoholic extract of fenugreek seeds and ‘usual care’ 
(dietary discretion and exercise), respectively. It was reported that both groups 
experienced a reduction in fasting blood glucose levels without significant differences, 
but significantly lower levels for blood glucose and insulin were observed in the diabetic 
group. This suggests that fenugreek seed extracts and a discrete diet/ exercise habit may 
be equally effective in the control of blood glucose and insulin levels (Basch et al., 2003).  
   Amin et al. (1987) reported that fenugreek seeds exerted hypoglycaemic effects 
by inhibiting the activities of -amylase and sucrase. More recent studies have also 
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associated the therapeutic effectiveness of fenugreek with beneficial counter-changes in 
enzyme activity in glucose and lipid metabolism (Gupta et al., 1999; Raju et al., 2001). 
They assessed the effect of fenugreek whole seed powder administered to alloxan-
induced diabetic rats on glycolytic, gluconeogenic and nicotinamide adenine dinucleotide 
phosphate (NADP)-linked lipogenic enzymes in liver and kidney tissues. A favourable 
restoration of activity of these enzymes to control levels was reported following 
fenugreek treatment, resulting in stabilization of glucose homeostasis. A potential 
therapeutic role for fenugreek in the treatment of type-1 diabetes was suggested. 
Recently, Hannan et al. (2007) looked at the inhibitory effects of a SDF fraction from 
fenugreek on the activity of digestive enzymes in vivo. Their findings suggest that the 
reduction in sucrose absorption seen following fenugreek treatment may be related to 
inhibition of disaccharidase (sucrase) activity in the gut. Although the mode of action for 
SDF in diabetes management is still not well understood in human test subjects, 
fenugreek galactomannan, as exemplified by the various animal and clinical studies, can 
be an effective support therapy in the control of this disease. 
   Fenugreek galactomannan has also been shown to have hypocholesterolaemic 
properties in diabetic dogs and non-diabetic rats (Sharma, 1986a; Ribes et al., 1987). In 
humans, Sharma et al. (1991) found that treatment of 15 hyperlipidemic adults who were 
fed 100 g of defatted fenugreek daily over a three-week period had lower blood 
cholesterol levels. These test subjects reported lower than baseline values for triglyceride 
and low-density lipoprotein (LDL) cholesterol. Sowmya and Rajyalakshmi (1999) 
conducted a study to assess the effect of germinated fenugreek seed consumption in 
human subjects on cholesterol levels. It was revealed that germination drastically 
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increased the soluble fiber content in fenugreek seeds. Consumption of these seeds 
brought about a significant reduction in total and LDL cholesterol levels, although no 
significant changes were observed for high density-lipoprotein (HDL), very low-density 
lipoprotein (VLDL) cholesterol and triglyceride levels. In a similar study by Gupta et al. 
(2001), the diabetic group showed a significant decrease in serum triglyceride levels and 
a similar increase in high-density lipoprotein (HDL) levels when compared to normal test 
subjects. A more recent study by Venkatesan et al. (2003) investigated the 
hypocholesterolemic effects of a unique dietary fiber (‘Fibernat’), which is a combination 
of fenugreek seed powder, guar gum and wheat bran, in rats. The study examined lipid 
metabolism and cholesterol homeostasis by determining the activity of hepatic 
triglyceride lipase (HTGL) and uptake of atherogenic lipoproteins (LDL and VLDL) by 
the hepatic apo B, E receptor. Fibernat was successful in increasing both apo B and E 
receptor expression in the liver and activity of HTGL, giving rise to a marked 
hypocholesterolemic effect and establishment of an improved cholesterol homeostasis in 
Fibernat-fed rats.  
   It has been suggested that formation of a physical barrier in the gut by the 
viscous fraction of fenugreek may aid in inhibition of bile salt absorption in the intestine 
or may possibly cause intra-luminal binding of cellular receptors, resulting in increased 
fecal extraction of bile acids and neutral sterols. In both cases, existing cholesterol is 
converted to bile acids, hence decreasing plasma cholesterol levels (Madar and Shomer, 
1990; Venkatesan et al., 2003). This has been demonstrated in a recent study by Dakam 
et al. (2007), which looked at the physiological properties of fenugreek galactomannan in 
rats. Using male abino Wistar rats, they divided the animals into three groups according 
 34 
 
to their diet over a period of 4 weeks; i.e., galactomannan (gum), gum + sodium 
bicarbonate, gum + albumin. The researchers reported a significant decrease in plasma 
total cholesterol in all three groups, with the greatest decrease in LDL-cholesterol for the 
gum + albumin group. They hypothesized that the combination of albumin (protein) with 
galactomannan contributed to the viscosity associated with the gum solutions 
administered, and consequently may offer better protection against coronary heart 
disease.  
 
2.12.2 Diosgenin  
 Diosgenin is a 27-carbon steroidal compound with the chemical name (25R)-
spirost-5-en-3--ol (Fig. 2.14) and is one of the many sapogenins found in fenugreek 
seed, also derived from yams (Dioscorea spp.) (Sauvaire and Baccou, 1978). It is 
currently an important raw material for the manufacturing of pharmaceutical hormones 
and steroids such as estrogen, progesterone, testosterone and glucocorticoids (Skaltsa, 
2002). Diosgenin occurs naturally as a glycosylated compound in fenugreek, and can be 
liberated by acid hydrolysis (which removes three carbohydrate residues) of the steroidal 
saponin, dioscin (Fig. 2.14) (Dewick, 1997; Sauvaire et al., 1991). 
 Diosgenin is synthesized as part of the melavonate pathway in the biosynthesis 
of steroids (C18-C30). Steroids are modified triterpenoids which contain a tetracylic ring 
structure of lanosterol (Fig. 2.15) but lack the three methyl groups at C-4 and C-14 
(Dewick, 1997). Lanosterol is a precursor to the biosynthesis of plant cholesterol, which 
in turn is the most fundamental structure of a plant steroid. Steroidal diosgenin is formed 
 35 
 
by modification of the side chain of cholesterol, in which a spiroketal structure is formed 
at C-22, yielding a non-polar compound with 6 carbon rings. 
 
     
 
            (A)                                                                                  (B) 
Figure 2.14 Chemical structure of dioscin (A) and diosgenin (B). 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2.15 Chemical structure of lanosterol (A), the precursor to the biosynthesis of 
cholesterol (B) and other phytosterols in plants. 
(A) (B) 
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Hydrolyzed chemical extracts (i.e., in ethanol/ methanol) of fenugreek seeds 
yield a mixture of steroidal sapogenins (Marker et al., 1947 cited in Skaltsa, 2002). These 
extracts contain major sapogenins such as diosgenin, yamogenin, tigogenin, 
neotigogenin, smilagenin and sarsapogenin, and minor compounds such as yuccagenin, 
gitogenin and neogitogenin (Fazli and Hardman, 1971; Gupta et al., 1986; Sauvaire et al., 
1996; Taylor et al., 1997; Petropoulos, 2002). Depending upon biogeographic origins, 
genotypes and environmental factors, reported diosgenin contents in fenugreek vary 
between 0.3 and 2.0% (Fazli and Hardman, 1968 cited in Petropoulos, 2002; Puri et al., 
1976; Sharma and Kamal, 1982; Taylor et al., 2002). It has been demonstrated that 
fenugreek with similar genotypes grown in different environments and geographical 
locations, can possess significantly different plant chemical compositions (Acharya et al., 
2006; Thomas et al., 2006; Taylor et al., 1997) resulting from genotype x environment 
interactions.  
 Atherosclerosis (the narrowing of blood vessels) is associated with high levels 
of LDL- and VLDL-cholesterol and is a major cause of cardiovascular disease 
(Srinivasan, 2006). Therefore, a reduction in LDL-cholesterol is considered essential to 
reducing the risk of a heart disease. Laguna et al. (1962; cited in Sauvaire et al., 1991) 
reported that diosgenin treatment was able to lower plasma cholesterol concentrations in 
chickens and rabbits fed with cholesterol. In another study, diabetic rats were fed with 
steroidal saponin extracts from fenugreek and a reduction in both VLDL and LDL total 
cholesterol was observed (Sauvaire et al., 1996). Ribes et al. (1987) treated diabetic dogs 
with extracts of germinated fenugreek seeds containing large amounts of protein (52.8 %) 
and saponins (7.2 %), and reported a significant decrease in triglycerides and plasma 
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cholesterol concentrations in these animals. Further analysis using extracts containing a 
saponin concentration as high as 22% (w/v) produced a sharp decrease in LDL-
cholesterol levels whereas a high protein-containing extract (70.5%) did not produce 
similar effects. Steroidal saponins and/or sapogenins (diosgenin) have been studied by 
Sauvaire et al. (1991) and were specifically implicated, either alone or synergistically in 
the hypocholesterolemic effect of fenugreek seeds in diabetic dogs.  
   Stark and Madar (1993) investigated the hypocholesterolemic potential of an 
ethanol extract from defatted fenugreek seeds in vitro as well as in vivo in 
hypercholesterolemic rats. In vitro, the purified ethanol extract exhibited the ability to 
inhibit bile salt absorption in a dose-dependent manner. Reductions in plasma cholesterol 
levels (18-26%) and lower concentrations of liver cholesterol were observed in vivo. This 
study attributed the decrease in cholesterol absorption observed to an interaction of 
saponins with bile salts in the digestive tract. These findings seem to agree with those of 
Bhat et al. (1985) and Sharma (1984), in which an increase of both fecal weight and bile 
acid excretion was observed in treated subjects following consumption of a fenugreek-
enriched diet. 
   It has been suggested that the hypocholesterolemic effect of diosgenin can be 
attributed to inhibition of cholesterol absorption, and its capacity to increase biliary 
cholesterol secretion and to increase neutral sterol excretion in feces (Cayen and Dvornik, 
1979 cited in Al-Habori and Raman, 2002; Uchida et al., 1984; Ulloa and Nervi, 1985). It 
is also postulated that formation of large mixed micelles containing bile salts and 
saponins in the gut inhibits the absorption of these molecules; hence they are lost in the 
feces. This would lead to a subsequent increase in conversion of cholesterol to bile acids 
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in the liver, thereby lowering blood and hepatic cholesterol levels (Al-Habori and Raman, 
2002). 
   Saponins also appear to selectively inhibit the growth of tumor cells by arresting 
their growth within the cell cycle and inducing them to initiate apoptosis or programmed 
cell death (Francis et al., 2002). Other studies have specifically linked diosgenin with 
cancer prevention (Raju et al., 2004; Liagre et al., 2005; Aggarwal and Shishodia, 2006). 
It was shown that diosgenin is needed in the inhibition and/or activation of key proteins 
(i.e., bcl-2 and caspase-3) in mediating apoptosis in human colon cancer cells (Raju et al., 
2004). Liagre et al. (2005) has elucidated a mechanism of diosgenin-induced apoptosis in 
human erythroleukemia cells, and Shishodia and Aggarwal (2006) have identified a 
chemopreventative role for diosgenin against bone cancer through growth suppression 
and apoptosis induction in cancer cells. Diosgenin also has been reported as a potential 
therapeutic chemical that can be used to treat dementia in drug abusers with HIV 
infection and a history of intravenous drug abuse (Turchan-Cholewo et al., 2006). 
 
2.12.3  4-Hydroxyisoleucine 
 
   4-Hydroxyisoleucine is the most abundant free amino acid (up to 80 % of the 
total free amino acids) in fenugreek seeds (Fowden et al., 1973; Sauvaire et al., 1984). A 
recent study by Hajimehdipoor et al. (2008) determined the content of  
4-hydroxyisoleucine to be 0.4% in Iranian fenugreek seeds, while a previous publication 
reported a content of just 0.015% in Indian fenugreek seeds (Narender et al., 2006). The 
stereochemistry of this rare amino acid was subsequently described by Alcock et al. 
(1989) and is only found in specific plants such as those of the genus, Trigonella.  
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4-Hydroxyisoleucine exists in two isomeric forms; the major isomer has a (2S, 3R, 4S) 
configuration (Fig. 2.16) which accounts for 90 % of the total 4-hydroxyisoleucine found 
in the seeds, while the minor isomer has a (2R, 3R, 4S) configuration (Fig. 2.16) (Broca 
et al., 2000). Under specific conditions, such as high acidity, the linear form of 4-
hydroxyisoleucine may cyclicize into the lactone form (Fig. 2.17) (Broca et al., 2000). 
This unique amino acid has been shown to possess both hypoglycemic and insulinotropic 
properties in vitro and in vivo using animal and human models, making it a potential 
candidate as a antidiabetic agent (Sauvaire et al., 1998; Broca et al., 1999). 
Branched-chain amino acids such as valine, leucine and isoleucine (Fig. 2.18) are 
produced exclusively in plants. Since humans lack the enzymes needed to synthesize 
these amino acids, they represent essential amino acids that must be consumed as part of  
the human diet (Binder et al., 2007). 
4-Hydroxyisoleucine is a branched-chain amino acid that is produced almost 
exclusively in plants of the genus Trigonella. As its name suggests, 4-hydroxyisoleucine 
is formed through the hydroxylation of isoleucine (Haefelé et al., 1997). Formation of 
this amino acid in fenugreek is attributed to the activity of isoleucine hydroxylase, a 
dioxygenase that catalyzes the attachment of one atom of an oxygen molecule to C-4 of 
the amino acid, while the other oxygen atom is incorporated into 2-oxoglutarate to yield 
succinate and carbon dioxide (Haefelé et al., 1997). The same study also identified 2-
oxoglutarate, ascorbate, iron (II) and oxygen as essential co-factors and co-substrates that 
contribute towards the functionality of the enzyme. It is important to note that the linear 
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                                  (A)                                                                    (B) 
Figure 2.16 The two isomers of 4-hydroxyisoleucine; major isomer (2S, 3R, 4S) (A) 
and minor isomer (2R, 3R. 4S) (B). Source: Broca et al. (2000).  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 2.17 The lactone form of 4-hydroxyisoleucine. Source: Broca et al. (2000). 
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Figure 2.18 Biosynthesis of branched-chain amino acids, isoleucine and valine. 
Source: Paustian (2000). 
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form of 4-hydroxyisoleucine is necessary for it to be biologically active. The lactone 
form, which has a significantly altered chemistry, is inactive (Broca et al., 2000). Also, it 
has been indicated that full methylation (full branching along the carbon skeleton), at 
carbon- in the S-configuration and carbon- hydroxylation are required for its 
insulinotropic activity (Broca et al., 2000; Bhaumick, 2006). 
Treatment of subjects with 4-hydroxyisoleucine has been shown to result in 
insulin stimulating effects in animals, hence giving it anti-diabetic properties (Hillaire-
Buys et al., 1993; Petit et al., 1995a; Sauvaire et al., 1996). Sauvaire et al. (1996) 
reported that 4-hydroxyisoleucine treatments produced a concentration dependent insulin 
response both in vitro in cell cultures and in vivo in fasted dogs. They also showed that 4-
hydroxyisoleucine treatments were effective after oral administration and improved oral 
glucose tolerance. The amino acid was shown to stimulate pancreatic  cells to produce 
insulin directly in rats and human subjects. It was found that this effect was glucose-
dependent and occurred only at moderate (8.3 mM) to high concentrations (16.7 mM) 
(Sauvaire et al., 1998). Broca et al. (1999) studied the effects of 4-hydroxyisoleucine in 
normal and type-2 diabetic rats through intravenous and oral glucose tolerance tests. A 
single intravenous administration of 4-hydroxyisoleucine partially restored a glucose-
induced insulin response, while a subchronic administration of the compound reduced 
basal hyperglycemia and basal insulinemia, and significantly improved glucose tolerance 
in type 2 diabetic rats. They concluded that 4-hydroxyisoleucine imparted anti-diabetic 
effects through direct pancreatic  cell stimulation. 
   Obesity is a condition in which lipid accumulates excessively in the adipose 
tissue. Aside from genetic factors, this disease is also caused by various environmental 
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factors such as a high-fat diet (Weiser et al., 1997). If uncontrolled, obesity may be a risk 
factor for chronic diseases such as diabetes, hyperlipidemia and hypertension. Sharma et 
al. (1990) first reported a lipid lowering effect for fenugreek in type 1 diabetic patients. 
They found a significant reduction in total serum cholesterol, LDL- and VLDL-
cholesterol and triglycerides, indicating that fenugreek can be effective in the 
management of diabetes. In a placebo-controlled study by Bordia et al. (1997), fenugreek 
was found to significantly reduce blood lipids without affecting HDL-cholesterol in 
patients with both coronary heart disease and type 2 diabetes. In another study, whole 
fenugreek seed powder fed to alloxan-treated diabetic rats was shown to improve glucose 
homeostasis by altering glucose and lipid metabolic enzyme activities, indicating a 
possible therapeutic potential of fenugreek for type 1 diabetes (Raju et al., 2001). Hannan 
et al. (2003) used the soluble dietary fiber fraction of fenugreek to study its effect on 
lipidemia in type 2 diabetic models. A lack of 4-hydroxyisoleucine in these extracts may 
have contributed to failure in this study to identify a lipid lowering principle, even though 
positive therapeutic effects for fenugreek in the control of heart disease were identified.    
   Handa et al. (2005) conducted a study using obese mice that were fed a high-fat 
diet supplemented with 0.3-1.0% fenugreek seed extract (containing 20% 4-
hydroxyisoleucine). It was found that fenugreek seed extract significantly reduced total 
adipose tissue and liver weights and resulted in a decrease in liver triglyceride levels. 
They repeated the experiments with similar parameters using 4-hydroxyisoleucine alone 
and reported a decrease in plasma triglyceride levels following corn oil administration (a 
method that would promote an increase in blood triglyceride levels in the test subjects). 
Their results identified 4-hydroxyisoleucine as an effective agent in fenugreek seed 
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extracts that has potential for use in obesity prevention. In another study, Narender et al. 
(2006) used a high-fat diet (HFD) fed to dyslipidemic hamsters to examine the anti-
dyslipidemic properties of fenugreek. The HFD caused a 2 to 5-fold elevation in plasma 
triglycerides, total cholesterol, HDL-cholesterol, glycerol and free fatty acids (FFA) in 
the animals. However, following treatment with 4-hydroxyisoleucine (50 mg kg-1 b.w.), a 
significant decrease in plasma triglycerides (33%), total cholesterol (22%) and an 
increase in HDL-cholesterol (8.7%) was observed.  These results were similar to those 
obtained when fenofribrate, a triglyceride lowering drug was used under similar 
conditions (Koyama et al., 2004).  A 14% reduction in FFA and a 4.9% decrease in 
glycerol levels were also reported. The study concluded that 4-hydroxyisoleucine 
possessed both hyperglycemic as well as anti-dyslipidemic properties, which allowed it to 
decrease plasma triglycerides, cholesterol and free fatty acid levels in the test subjects. 
 
2.13  Safety/ Toxicology 
 
      Due to its documented historical and traditional use as a spice and medicinal 
herb in various parts of the world, fenugreek has been granted “Generally Recognized As 
Safe” (GRAS) status by the U.S. Food and Drug Administration (U.S. Food and Drug 
Administration, 2006). However, caution is warranted in patients who are allergic to 
fenugreek (Patil et al., 1997). Ohnuma et al. (1998) have reported that a patient with an 
allergy to curry powder containing fenugreek responded with severe bronchospasms, 
wheezing and diarrhea. Tiran (2003) reported that a significant number of patients had an 
allergenic reaction to fenugreek in a skin test-patch. Transient diarrhea, flatulence and 
dizziness have also been reported as side effects of fenugreek consumption (Sharma et al., 
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1996a; Abdel-Barry et al., 2000). Bartley et al. (1981) suggested that fenugreek 
consumption can elicit a maple syrup-like odor in urine and may potentially cause the 
misdiagnosis of maple syrup urine disease.  
   There also is potential of chemical components in fenugreek to interact with 
other drugs during patient medication (Ernst et al., 2001). Bioactive components in 
fenugreek such as dietary fiber (i.e., galactomannan) and steroids (i.e., diosgenin), which 
have the potential to affect glucose and cholesterol levels in humans, could pose risk to 
individuals with health problems. Consumption of fenugreek can lead to hypoglycemia; 
hence proper blood glucose monitoring may be necessary for patients prior to use of 
fenugreek as a dietary supplement but significant clinically harmful adverse effects due to 
consumption of fenugreek as a food or medicinal supplement have not been reported 
(Basch et al., 2003). 
    Most reports on the toxicity of fenugreek consumption were obtained from 
studies with laboratory animals. Shlosberg and Egyed (1983) reported that ruminants that 
consumed fenugreek appeared to become myopic. Nakhla et al. (1991) also reported 
finding pathological abnormalities in the liver and kidney, along with reduced body 
weight and increased concentrations of uric acid in the blood in Sudanese chicks that had 
been fed fenugreek. Panda et al. (1999) have reported a decrease in body weight due to 
the inhibition of triiodothyronine (T3) production in mice and rats. Fenugreek 
preparations contain coumarin or its derivatives, which are anti-coagulants that prevent 
blood clotting (Lee et al., 2000; Lambert and Cormier, 2001). This will increase the risk 
of internal bleeding in patients who are taking blood-clotting drugs such as warfarin, as 
the coumarin in fenugreek may increase the activity of these drugs. Use of fenugreek 
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during pregnancy is also discouraged as saponins in the plant may stimulate uterine 
contractions leading to premature abortion of the fetus as observed in early animal studies 
(Abdo and al-Kafawi, 1969; Basch et al., 2003). In an animal study, an acute oral LD50 
was reported to be more than 5 g kg-1 in rats and an acute dermal LD50 was found to be 
more than 2g kg-1 in rabbits (Opdyke, 1978; Basch et al., 2003). In another animal study, 
the diets of mice and rats were supplemented with 1-10 % debitterized fenugreek powder, 
an approach which likely removes many of the saponins. No signs of toxicity or mortality 
in laboratory animals that received acute and subchronic regimens were observed 
(Muralidhara et al., 1999). Rao et al. (1996) conducted a nutritional and safety evaluation 
of fenugreek over a short term in weanling rats. The rats’ diet was supplemented with 5-
20% fenugreek powder over a 90-day period; the studies concluded that fenugreek 
appeared to be non-toxic in doses administered to the animals, within that time frame. 
However, a recent evaluation conducted by Kassem et al. (2006) reported a potential 
anti-fertility effect of fenugreek in rabbits. Through a diet containing 30 % fenugreek 
seeds, these researchers reported a significant anti-fertility effect in female rabbits and a 
toxicity effect in male rabbits. A significant reduction in developing fetuses was observed 
in females at 20 days of gestation and a histo-pathological assessment of the testis in 
male rabbits revealed damaged seminiferous tubules and interstitial tissues. 
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2.14  Crop genotype assessment: Biometrical aspects 
2.14.1  Genotype x environment interaction 
     Most crop breeding studies which aim at selecting genotypes that are superior in 
traits of agronomic interest (e.g., high-yielding or disease resistant plants) face two 
fundamental research problems: interaction and noise (Gauch and Zobel, 1996). Without 
interaction, a particular crop genotype would perform similarly all over the world, and 
without noise an experiment would not require replications, as the results would be 
indifferent. However, in a practical world, crop trials require a multi-environment design 
as variation in crop response to growing conditions (i.e., agro-climatic regions) and 
yearly variation does occur (Yan et al., 2001; Yang et al., 2005). Replication of 
experimental trials is also necessary to establish a valid data set where statistical 
differences among the results can be rationally determined (Gauch and Zobel, 1997). 
The ultimate goal of crop breeders is to identify superior genotypes that thrive in all 
environments. This objective is usually hampered by a phenomenon known commonly as 
the “genotype x environment interaction.” Such an interaction can cause similar sets of 
cultivars to acquire different performance rankings at different growing locations, 
resulting in inconsistent performance of genotypes across different environments 
(DeLacy et al., 1990). This makes cultivar evaluation meaningless if it cannot be 
characterized over a large range of test sites to include varying regional climatic 
characteristics. In the face of limited resources and the increasing need for more cost-
effective cultivar testing (Yang et al., 2005), yield-maximizing crop breeding programs in 
the past decades have focused on identifying genotypes that are stable across 
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homogenous growing environments (targeted sites with similar biotic, abiotic and 
management conditions) (Yan et al., 2000). Consequently, this warrants multi-
environment trials (MET) in which a number of genotypes are tested over a range of 
environmental conditions (Mohammadi et al., 2007).  
 
2.14.2  Multi-environment trials  
 
   In most multi-environment trials, main environment effect account for about 
80% of the total variation observed while genotype and genotype x location effects 
account for about 10% of the total variation observed (Gauch and Zobel, 1996; Yan et al., 
2000). Similar to generic crop traits such as seed yield or plant height, levels of plant 
structural components and secondary metabolites can vary among and within species due 
to genotypic differences (Amar et al., 2008). In addition, selection for superior genotypes 
can be complicated by the presence of an environment interaction factor, which can cause 
genetically similar plant lines to perform differently when grown under varying 
environmental conditions (DeLacy et al., 1990).  The international wheat trial by Braun 
et al. (1996) exemplifies this concept, in which they identified 12 regional locations in 
various developing countries across continents, grouped according to their latitude, soil 
conditions and agro-climatic characteristics, and collectively known as “mega 
environments.” Gauch and Zobel (1996) defined mega environments as, “a portion of a 
crop species’ growing region with a homogenous growing environment that causes some 
genotypes to perform similarly.”  
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2.14.3 Yield stability analysis 
 
    Gauch and Zobel (1997) demonstrated the concept of mega environments 
mentioned above using an Additive Main effects and Multiplicative Interaction (AMMI) 
model to analyze a MET data set for maize (Zea mays L.). Their “which-wins-where” 
methodology assisted in identifying facilitating locations (mega environments) for 
genotypes with superior crop performance. The AMMI model incorporates the additive 
portion of the variance using an analysis of variance (ANOVA) for the genotype main 
effect and later applies a principal component analysis (PCA) to identify multiplicative 
interaction effects (Gauch and Zobel, 1996). An AMMI biplot can be generated based on 
the first and second principle component scores for genotype and environment plotted 
against each other to analyze the interaction effect from the ANOVA model. The biplot, 
based on the concept of matrix multiplication was first developed by Gabriel (1971) and 
has evolved into a data visualization tool that is highly cost-effective in yield trials for 
determining mega environments and identifying winning genotypes (Yan et al., 2007).  
An arguably equivalent analysis resembling AMMI is the genotype plus 
genotype x environment (GGE) biplot technique by Yan (1999). The term GGE is a 
contraction of genotype (G) + genotype-environment interaction (GE) and is based on the 
assumption that the environment main effect, although large is irrelevant to genotype 
evaluation; hence it is removed from the data. Only G and GE effects, when considered 
simultaneously, are useful for meaningful genotype evaluation (Yan and Kang, 2003). 
The basic model for a GGE biplot is given as: 
 Ŷij = µ + αi + βj + Φij      [Equation 1] 
or 
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   Ŷij - µ - βj = αi + Φij      [Equation 2]  
where Ŷij is the expected yield of genotype i in environment j, µ is the grand mean of all 
observations, αi is the main effect of genotype i, βj is the main effect of environment j, 
and Φij is the interaction between genotype i and environment j. The model then further 
partitions G and GE into two multiplicative terms: 
   Ŷij - µ - βj = gi1e1j + gi2e2j + εij   [Equation 3] 
where gi1 and e1j are the primary scores for genotype i and environment j, respectively, gi2 
and e2j  are the secondary scores for genotype i and environment j, respectively, and εij is 
the residue not explained by the primary and secondary effects. The plotting of gi1
 against gi2, and e1j against e2j  in a single scatter plot, ultimately constructs the GGE 
biplot (Yan and Kang, 2003). 
The “which won where” view is one key feature of the GGE biplot and consists 
of an irregular polygon with perpendicular lines drawn from the biplot origin, dividing 
the polygon into sectors (hypothetical mega environments) with winning cultivars located 
at the vertices of the polygon, within each sector (Yan et al., 2000; Yan et al., 2002). This 
technique has been widely adapted and used by plant breeders and agronomists 
worldwide for crops including durum wheat (Letta et al., 2008), rice (Tabien et al., 
2008), lentil (Sabaghnia et al., 2008), barley (Dehghani et al., 2006) and corn (Samonte 
et al., 2005) to identify superior cultivars and facilitate identification of environmental 
factors. 
   Both the AMMI model and GGE biplot analysis are very useful tools for 
analysis of MET data. However, these models are only valid for trials with fixed effects, 
as the ANOVA portion of the models utilizes the General Linear Model (Equation 1), 
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which is incapable of making an inference of results that reflect random effects (Yang, 
2008). Since in the present study, genotype and growing environment were considered as 
fixed and random factors, respectively, the application of either the AMMI or the GGE 
biplot models to elucidate, particularly the interaction component would therefore be 
statistically inappropriate. Despite that, Yan et al. (2001) has emphasized the usefulness 
of the biplot technique such as the GGE biplot analysis to provide graphically 
informative and highly convenient figures for visual identification of high-yielding 
genotypes and their potential environments.  
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3.0 Materials and Methods 
 
3.1 Fenugreek seed material 
The ten fenugreek genotypes used in this study were of Trigonella foenum-graecum 
L. Seeds of these genotypes originated from different agro-ecological locations in the 
world, including Afghanistan, India, Iran, Pakistan, and Turkey (Table 3.1). They were 
obtained from USDA/ARS in Pullman, Washington and further selected for high seed 
yield and/or forage yield as well as early maturity traits at CDCS, Brooks, Alberta, 
Canada with the exception of Tristar (selected at AAFC, Lethbridge, Alberta, Canada), 
L3312 (obtained from Plant Gene Resources of Canada, Saskatoon, Saskatchewan, 
Canada), Quatro MP 30 (selected at the Crop Development Centre, Saskatoon, 
Saskatchewan, Canada), AC Amber (selected at AAFC, Morden, Manitoba, Canada) and 
X92-32-23T (a zero-tannin line from the collection of the University of Saskatchewan, 
Saskatoon, Saskatchewan, Canada).  
 
3.2  Growing environments 
The multi-environment study was conducted over two cropping years (2006 and 
2007) at three locations; i.e., Brooks, Bow Island and Lethbridge in southern Alberta, 
where both rainfed and irrigated growing conditions of the Brown soil zones in western 
Canada were represented. In 2007, another site within the Lethbridge area was added to 
the study (Lethbridge – Provincial). For statistical purposes, the year x growing condition 
x location contribution is considered as a growing environment (Lin and Binns, 1991), 
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Table 3.1 Fenugreek genotypes and their origins, used in the study. 
Fenugreek genotypes/ cultivar Origin 
Tristar Selected at Agriculture and Agri-
Food Canada, Lethbridge, Alberta, 
Canada 
Quatro MP 30  Line of the Crop Development 
Centre, Saskatoon, Saskatchewan, 
Canada 
AC Amber (Amber) Selected at Agriculture and Agri-
Food Canada, Morden, Manitoba, 
Canada 
F17 Seeds obtained from the United 
States Department of Agriculture/ 
Agricultural Research Station in 
Washington, and lines have been 
selected for prairie growth at the 
Crop Diversification Centre South, 
Brooks, Alberta, Canada 
Iran 
F75 Afghanistan 
F96 Italy 
F86 Afghanistan 
X92-23-32T (X92) Origin unknown (Obtained from the 
University of Saskatchewan, 
Saskatoon, Canada) 
Indian Temple (Ind Temp) Imported from India (Indian origin) 
L3312 Obtained from Plant Gene Resources 
Canada, Saskatoon, Saskatchewan, 
Canada 
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which produced a multi-environment study with a total of fourteen growing environments.  
The soil type and growing conditions of test sites are given in Table 3.2. The 
fenugreek genotypes were seeded into 4.5 m or 6.0 m long plots with four or six rows 
spaced 30 cm or 20 cm apart, depending upon the location, at a seeding rate between 27 - 
33 kg ha-1, depending upon seed size of the genotype, to receive a target plant population 
density of 130 seeds m-2. The plots were arranged in a Randomized Complete Block 
Design with two replicates at each growing environment. The crop was grown using 
cultural practices recommended by Alberta Agriculture and Rural Development.  
At maturity, after eliminating borders, depending upon the location, individual plot area 
of 4.2m2 or 7.2 m2 at each test site was mechanically harvested, the seed dried in a 
ventilated dryer at 32 ºC for several days to bring the seed moisture levels to about 6 %, 
and plot seed weights and 1000-seed weights were determined. 
 
3.2.1 Brooks 
              Brooks, Alberta (50 33' N and 111 55' W, Ele. 758 m) is located about 168 km 
east of Calgary along the Trans-Canada Highway (Environment Canada, 2008). Orthic 
Brown Chernozem is the dominant soil type in this area (Wyatt et al., 1939). The annual 
average maximum and minimum temperatures for year 2006 were 13.3 C and -0.8 C, 
respectively, and for year 2007 were 12.7 ºC and -1.5 ºC, respectively. The estimated
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Table 3.2 Descriptions of the fourteen growing environments used in this study. 
Environment  Location description Soil type 
Mean max and 
min temperatures 
May to September 
Available Water 
May to Sept. Reference 
2006 
Brooks 
Irrigated  
(BR-Irr-06) 50º 31'  23'' N and 111º  47' 19'' W 
 
Brown Chernozem, 
silt soil 24.7 °C / 8.4 °C  
316 mm 
Wyatt et al., 
1939; IMCIN, 
2008 
Rainfed  
(BR-Dry-06) 157 mm 
Bow Island 
Irrigated  
(BI-Irr-06) 49° 52' 5'' N and 
111° 21' 58'' W 
Orthic Brown 
Chernozem 24.4 °C / 9.1 °C  
330 mm 
Rainfed  
(BI-Dry-06) 115 mm 
Lethbridge 
Irrigated  
(LB1-Irr-06) 
 
49º 41' 39'' N and 
112º 45' 42'' W 
 
Orthic Dark Brown 
Chernozem  31.5 ºC/ 1.8 ºC 
293 mm 
Rainfed  
(LB1-Dry-06) 141 mm 
2007 
 
Brooks 
Irrigated  
(BR-Irr-07) 49° 44' 2'' N and 
111° 27' 36'' W 
Brown Chernozem, 
silt soil 23.8 °C / 7.9 °C 
165 mm 
Wyatt et al., 
1939; 
IMCIN, 2008 
Rainfed 
(BR-Dry-07) 85 mm 
Bow Island 
Irrigated  
(BI-Irr-07) 50º 31' 23'' N and 
111º  47' 19'' W 
Orthic Brown 
Chernozem 24.1 °C / 8.8 °C 
407 mm 
Rainfed 
(BI-Dry-07) 107 mm 
Lethbridge 
(Federal) 
Irrigated  
(LB1-Irr-07) 
 
49º 42' 21'' N and 
112º 45' 44'' W 
 
Orthic Dark Brown 
Chernozem 30.1 ºC/ 2.4 ºC  
337 mm 
Rainfed 
(LB1-Dry-07) 83 mm 
Lethbridge 
(Provincial) 
Irrigated  
(LB2-Irr-07) 49º 41' 10'' N and 
112º 44' 38'' W 
Orthic Dark Brown 
Chernozem  30.1 ºC / 2.4 ºC 
105 mm 
Rainfed 
(LB2-Dry-07) 80 mm 
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annual total precipitation for 2006 and 2007 was 241.5 mm and 292.3 mm, respectively 
[Irrigation Management Climate Information Network (IMCIN), 2008]. The GPS 
coordinates for the test sites in Brooks are 50º 31' 23'' N and 111º  47' 19'' W. 
 
3.2.2 Bow Island 
   Bow Island Alberta (49 44' N and 111 27' W, Ele. 817 m) is located about 322 
km southeast of Calgary on the Alberta Highway 3 (Environment Canada, 2008). The 
predominant soil type in this area is Brown Chernozem and silty soil. The average annual 
maximum and minimum temperatures for 2006 were 13.8 C and 0.4 C, respectively, 
and for 2007, 13.1 ºC and 0.0 ºC, respectively. Total precipitation for 2006 and 2007 was 
recorded at 230.8 mm, and 304.2 mm, respectively (IMCIN, 2008). The GPS coordinates 
for the test sites in Bow Island are 49° 52' 5'' N and 111° 21' 58'' W. 
 
3.2.3 Lethbridge (Federal test site) 
   Lethbridge, Alberta (49 45 N and 112 45' W, Ele. 929 m) is located 
approximately 216 km southeast of Calgary, situated on both sides of the Oldman River 
(Environment Canada, 2008). The soil type predominant in this area is Orthic Dark 
Brown Chernozem (Wyatt et al., 1939). The annual average maximum and minimum 
temperatures for 2006 were 14.0 C and -0.6 C, respectively, and for 2007 were 12.8 ºC 
and 0.1 ºC, respectively. The total precipitation recorded for 2006 and 2007 was 284.9 
mm and 288.2 mm, respectively (IMCIN, 2008). 
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3.2.4 Lethbridge (Provincial test site) 
In 2007, another site referred to as Lethbridge (Provincial) was added to the 
study.  The site bears the location coordinates 49º 41' 10'' N and 112º 44' 38'' W,  
Ele. 903 m (Environment Canada, 2008). Soil type was the same as that found at the 
Lethbridge (Federal) site. The annual average maximum and minimum temperatures as 
well as total precipitation for both 2006 and 2007 were similar to those given for the 
Lethbridge (Federal) site. 
 
3.3  Agronomic and biochemical traits evaluated in the study 
Eight agronomical and biochemical traits assessed in this study include mean seed 
weight, expressed as thousand seed weight (TSW, in g), seed yield (SY as kg ha-1), 
galactomannan content (GLM as %), galactomannan productivity (GLM-P as kg ha-1), 
diosgenin content (DIOS as %), diosgenin productivity (DIOS-P as kg ha-1), 
 4-hydroxyisoleucine content (4-OH-ILE as %) and 4-hydroxyisoleucine productivity  
(4-OH-ILE-P as kg ha-1).  The individual bioactive compound productivity was 
calculated by multiplying the respective bioactive compound content (%) by seed yield 
(kg ha-1). 
 For the biochemical analyses, approximately 100 g of whole seed was ground in 
a household coffee grinder for 15 seconds. The ground material was visually inspected to 
ensure a homogenous sample. The powdered fenugreek seed was transferred into 
envelopes (unsealed) and stored at room temperature until use. Prior to sub-sampling, the 
sample material in the envelope is stirred to provide a representative sample. 
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3.4  Estimation of galactomannan content 
Galactomannan contents (GLM) for mature seed were determined using a 
commercially available assay kit (Megazyme Int., Bray, Ireland). The protocol utilized 
sequential enzymatic hydrolysis of galactomannan molecules to release free galactose 
into solution. Quantification was achieved through a redox reaction with nicotinamide 
adenine dinucleotide (NAD+) yielding NADH and the lactone form of galactose, 
followed by UV detection (λ = 340 nm) of NADH to calculate the galactomannan content 
assuming a galactose/mannose ratio of 1:1. Galactomannan contents were measured in 
percentages in relation to dry seed material with a 5% moisture content basis. 
Measurements were carried out in duplicate along with a control sample using carob 
powder with a given galactomannan content of 36% (“as is” basis). Recovery of the 
control sample averaged 89.50% (n = 26) with a coefficient of variation (CV) of 1.37 %, 
on a day-to-day basis. Each of the selected fenugreek genotypes was replicated in the 
field (20 samples), and each replication was analyzed in duplicates (40 measurements). 
Approximately 100 g of whole fenugreek seed (approximately 100 mg of powdered 
sample) material was initially extracted with aqueous ethanol (80% v/v) to remove 
galactosyl sucrose oligosaccharides, which can be a source of non-galactomannan 
derived galactose residues. The ethanol-treated sample was then suspended in 8 mL of 
acetate buffer (100 mM, pH 4.5) and placed in a heating block (Multi-Block, Labline 
Instruments, IL) at 90 °C for 30 seconds followed with vigorous vortexing before 
returning the sample to the heating block for another 30 seconds, followed by more 
vigorous vortexing. The sample was returned to the heating block for another 4 minutes 
to complete galactomannan hydration. The samples were then allowed to cool to 40 °C in 
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a water bath prior to addition of 10 L -mannanase (450 U mL-1), followed by 
incubation at 40 °C for 1hour, with intermittent stirring. The hydrolyzed solution was 
quantitatively transferred to a 25 mL volumetric flask, and made up to volume with 
distilled water. The solution (10 mL) was centrifuged at 4000 rpm for 10 minutes, and the 
supernatant was used in the final enzymatic procedure. The supernatant (200 L) was 
transferred to a cuvette containing 100 L acetate buffer and 20 L of -galactosidase 
(150 U mL-1) and -mannanase (50 U mL-1), in combination and was incubated at 40 °C 
to effect complete hydrolysis of the galactomannan molecule.  Tris/hydrochloric acid 
buffer (100 L) , nicotinamide adenine dinucleotide (NAD+) solution (100 L) were 
mixed with 2.3 mL of distilled water and then added to a cuvette. The absorbance of the 
solution was determined at 340 nm, against a blank solution using a Spectronic 1201 
diode array spectrophotometer (Milton Roy Co., Rochester, NY). The final enzymatic 
step was conducted with the addition of 20 L of -galactose dehydrogenase  
(200 U mL-1) to yield NADH and D-galactono-1,4-lactone.  
 
3.5 Estimation of diosgenin content 
This analytical method was developed with modifications based on the published 
methods of Wu and Wu (1991), Ortuño et al. (1998), Taylor et al. (2002) and Trivedi et 
al. (2007). In principle, the analysis involves hydrolysis of naturally occurring 
glycosylated dioscin to yield free diosgenin in solution, followed by repeated extractions 
with and subsequent evaporation of a non-polar solvent. The dry residue was redissolved 
in methanol prior to analysis with an Agilent 100 HPLC system (Agilent Technologies 
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Inc. Canada, Mississauga, ON) equipped with a photodiode array detector. Diosgenin 
contents were measured in percentages in relation to dry seed material with a 5% 
moisture content basis.  
Each fenugreek genotype with 2 replicates was measured in duplicate. Sample 
analysis was executed along with the analysis of a reference sample. The day-to-day 
variation expressed as coefficient of variation (CV) for diosgenin content of the reference 
sample was 3.79% (n = 82), while the CV for duplicate measurements of fenugreek 
samples was 3.47% (n = 20). Average accuracy of the method in terms of spike 
recoveries (diosgenin standard) was 82% (n = 33). Approximately 100 mg of powdered 
seed material was hydrolyzed with 3 mL of 1 M sulfuric acid in 100% ethanol for 30 
minutes at 100 °C in a heating block (Multi-Block, Labline Instruments, IL). After 
hydrolysis, the solution was diluted with 2 mL of distilled water. Repeated extraction of 
diosgenin was carried out using 2 mL of hexane as solvent. The accumulated hexane 
extract (~ 6 mL) was then washed with 2 mL of 0.1 M sodium hydroxide to neutralize the 
free fatty acids, followed by another 1 mL of distilled water wash to remove any 
remaining hydrophilic molecules. The washed hexane extract was quantitatively 
transferred to a recovery flask (50 mL), and evaporated to dryness with a rotary 
evaporator (Büchi Rotavapor-R, Brinkmann Instruments Canada Ltd., Toronto, ON) at 
50 °C. The dry residue was redissolved in 2 mL of methanol and an aliquot of the 
reconstituted solution was filtered through a 0.45 μm polypropylene membrane filter 
(Fisher Scientific Canada, Ottawa, ON) prior to HPLC analysis. Reversed-phased 
chromatography was executed using an isocratic separation with a 5 μm particle size, 4.6 
mm (i.d.) x 150 mm Luna C18 column (Phenomenex, Torrance, CA), at 14 °C, with a 
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flow rate of 1.0 mL-1, and 94% methanol mobile phase. Detection of the compound was 
achieved at 214 nm using a photodiode array detector. Quantitation of diosgenin in the 
sample was based upon the peak area of authentic diosgenin (Steraloids Inc., Newport, RI) 
as an external standard.  The retention time of diosgenin was approximately 9.9 min 
using this method. The separation of diosgenin from other structurally similar sapogenins 
is unlikely based on the efficiency of an HPLC system. The diosgenin peak observed 
would rationally include a variety of fenugreek sapogenins. The total sapogenin content 
of fenugreek seeds were reported as diosgenin for the purpose of this study. 
 
3.6 Estimation of 4-hydroxyisoleucine content 
This analytical method was developed with modifications based upon a protocol 
acquired from Chromadex Inc., Irvine, CA.  This method involves initial extraction of 
free 4-hydroxyisoleucine with aqueous methanol, followed by phenylisothiocyanate 
(PITC) derivatization to enable detection of the compound with a photodiode array 
detector at 254 nm following a gradient elution with an Agilent 1100 HPLC system 
(Agilent Technologies Inc. Canada, Mississauga, ON). 4-Hydroxyisoleucine content (4-
OH-ILE) was measured on a percentage basis in relation to dry seed material with 5 % 
moisture content. Each fenugreek line with 2 replicates was measured in duplicate. 
Sample analysis was carried out along with the analysis of a reference sample. The day-
to-day variation expressed as coefficient of variation (CV) for 4-OH-ILE of the reference 
sample was 2.27 % (n = 32) and the average CV for duplicate measurements of fenugreek 
samples was 2.02 % (n = 22). The determined accuracy for the method in terms of spike 
recovery (4-hydroxyisoleucine standard) was 114 % (n = 4). 
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Approximately 300 mg of powdered sample material was extracted with 3 mL 
aqueous methanol (50 % v/v) for 15 minutes on a magnetic stirrer at 600 rpm. This was 
followed by another 15 minutes of extraction in a Bransonic 220 sonicator (Branson 
Ultrasonics Corporation, Danbury, CT), to effect complete solubilization of the 
compound. The methanol extract (1 mL) was then mixed with 2.5 mL of coupling 
solution [67 % acetonitrile, 20 % water and 13 % triethylamine (Sigma-Aldrich, 
Oakville, ON)] and 50 L PITC (Sigma-Aldrich, Oakville, ON) in a 25 mL volumetric 
flask for compound derivatization. Methanol (15 mL) was added to the treated solution 
and was made up to volume with distilled water. The solution was filtered through a 0.45 
m polypropylene membrane prior to HPLC analysis. Separation of the analytes was 
achieved using 0.1 % phosphoric acid and acetonitrile (B) as the mobile phase through a 
gradient elution (t = 0 min, 20 % B; t = 24 min, 80 % B; t = 25 min, 0 % B for 1.5 min). 
A 20 L sample size was injected into a 5 m, 4.6 x 150 mm Luna C18 column 
(Phenomenex, Torrance, CA), at 30 °C, with a flow rate of 1.5 mL min-1. Retention time 
of 4-hydroxyisoleucine in the column was approximately 6.6 minutes using this method. 
The compound was quantified using an external standard curve based on authentic 4-
hydroxyisoleucine (purchased from ChromaDex Inc.). 
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3.7 Statistical analysis 
3.7.1 Analysis of main effects and assessment of associations among 
traits 
 
Treatment (genotype and growing environment) effects on thousand seed weight 
(TSW), seed yield (SY), galactomannan content (GLM), diosgenin content (DIOS), 4-
hydroxyisoleucine content (4-OH-ILE) and their respective productivity (GLM-P, DIOS-
P, 4-OH-ILE-P; ) were subjected to Analysis of Variance (ANOVA) in a Randomized 
Complete Block Design (RCBD) using PROC MIXED (SAS Institute, Cary, NC).  In the 
ANOVA model, the factor, genotype was considered as fixed, whereas replicate and 
growing environment were considered as random factors.  The treatment effects were 
further partitioned into main and interaction effects of genotype and growing 
environment for individual traits to assess their relative contributions to the total variation.   
Whenever the main effects of genotype and growing environment were significant 
at p ≤ 0.05, treatment means were compared for significance using Tukey’s Honestly 
Significant Difference test. The critical value, w (Equation 4) was calculated using 
differences between all pairs of means, at a p ≤ 0.05.                 
            w  q ( p, fe )sY        [Equation 4] 
 
where q  can be obtained from a table of “upper percentage points of the studentized 
range” originally produced by May (1952) cited in Steel and Torrie (1980) in which 
q Y maxY min) /sY , p = t = number of treatments,  fe is the error in the degrees of 
freedom and sY  is the error in the mean of the squares. Means were assigned similar 
superscripts if they were not significantly different from each other at a 95% confidence 
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level. Means that were not assigned superscripts are significantly different from all other 
means at a 95% confidence level. 
 
3.7.2 Interaction effect analysis 
In multivariate statistics, data dimensions reduction can be achieved using cluster 
analysis by simplifying the pattern of responses and by grouping both genotypes (G) and 
environments (E) into more homogenous categories.  The classification of genotypes or 
environments according to similar response patterns is essential for improving efficiency, 
especially in breeding programs. The procedure for cluster analysis (XLSTAT, Addinsoft, 
New York, NY) was used to identify homogenous groups (clusters) for genotypes based 
on selected trait performance. The clusters were grouped so that differences between 
subsets of clusters are due to significant G x E interactions (Lin et al., 1986); no 
interactions were observed within the subsets. Similarity of clusters was based on Pearson 
correlation coefficients (r-values), while agglomeration of the clusters was achieved 
using an unweighted pair group average method, where the distance between two clusters 
is calculated as the average distance between all pairs of objects in two separate clusters.  
The genotype plus genotype x environment (GGE) biplot methodology described 
by Yan (1999) was used to visualize winning genotypes and their environmental niches. 
This procedure grouped homogenous environments based on a similar genotype response 
and identifies the best performing genotypes at their most influential environments for the 
traits studied.  The biplot is constructed by plotting principal component scores for both 
genotype (entries) and environment (testers) simultaneously to create a two-dimensional 
diagram, using the first principal component (PC1) scores as the abscissa (horizontal 
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axis), and the second principal component (PC2) scores as the ordinate (vertical axis). 
The total variation relative to GGE explained by the biplot is given as percentages 
represented by PC1 and PC2, and is presented in the upper-left corner of the diagram. 
Entries (i.e., genotypes) are in lowercase and testers (i.e., environments or traits) are in 
uppercase. “Entries” which have a high PC1 score (positive) indicate superior 
performance while those that have a PC2 score close to zero indicate stability (Yan and 
Kang, 2003). The polygon-view or the “which won where” view of the GGE biplot 
presents a polygon drawn by connecting all the genotypes located farthest from the biplot 
origin, so that all genotypes are contained in the polygon. Perpendicular lines to each side 
of the polygon are drawn from the biplot origin dividing the polygon into sectors. 
Genotypes positioned at the vertices of the polygon are referred to as vertex genotypes. In 
relation to their distance to the biplot origin, these vertex genotypes also have the longest 
vectors in their respective directions, which are a measure of their responsiveness to 
environments. Genotypes positioned at the vertices are therefore the most responsive, 
while those contained in the polygon are less so, in their respective directions. Moreover, 
genotypes located close to the biplot origin responded similarly in all environments and 
hence were not at all responsive to the environments. The vertex genotype is the highest-
yielding genotype in all environments that share the sector with it.   
 The nature of association among the traits considered in this study was 
determined by performing a Pearson correlation analysis using MINITAB Statistical 
Software (Minitab Inc., State College, PA). To provide a graphical representation of the 
association of traits, the GGE biplot analysis was also performed to provide a “which 
won what” view which eventually provided information for the respective trait profiles of 
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each genotype. The distance of an environment from the biplot origin is referred to as the 
tester’s vector and its length is a direct indication of the environment’s ability to 
discriminate among the genotypes. For example, a relatively short vector implies that the 
environment generates similar response among genotypes and any observed differences 
for genotypes tested in that environment may be a reflection of experimental noise, and 
hence may not be reliable.  The angle of separation between testers can also estimate the 
correlation among them; an acute angle ( < 90º), obtuse angle ( > 90º) and right angle 
( = 90º) shows positive, negative and no correlation between them, respectively (Yan et 
al., 2001).   
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4.0 Results  
 
4.1 Impact of genotypes and growing environments on selected 
agronomical and biochemical traits of fenugreek 
 
This study was conducted at six locations in 2006 and eight locations in 2007. 
These locations and test years were collectively considered ‘growing environments’, 
consequently producing a total of fourteen growing environments for this study. At each 
growing environment, ten fenugreek genotypes were evaluated for eight selected 
agronomic and biochemical traits namely mean seed weight expressed as 1000-seed 
weight (TSW), seed yield (SY), galactomannan content (GLM), galactomannan 
productivity (GLM-P), diosgenin content (DIOS), diosgenin productivity (DIOS-P),  
4-hydroxyisoleucine content (4-OH-ILE) and 4-hydroxyisoleucine productivity (4-OH-
ILE-P). The relative impact and significance of the growing condition and genotype for 
the selected traits were assessed by performing an Analysis of Variance (ANOVA) using 
a mixed model where the genotype and the growing environment were considered fixed 
and random factors, respectively.  
 
4.1.1 Main effects of genotype and growing environment on selected 
traits 
 
A summary of the ANOVA results indicating degrees of freedom and sums of 
squares for growing environment (E), genotype (G) and G x E interactions and their 
significance for individual traits is given in Table 4.1. Results indicate that the main 
effects of G, and E and the G x E interaction effect are significant for all traits measured 
at p  0.01. The relative impact of the effects of G and E, and the G x E interaction on 
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evaluated traits is given in Table 4.2, considering the total variation due to treatment 
equals 100%. Results indicated that the main effect of E had the highest contribution to 
the total variation due to treatments for all the traits tested, which varied from 63% for 
TSW to 78% for 4-OH-ILE, except for DIOS where the main effect of E contributed only 
6%. With the exception for DIOS, the contribution of G for other traits tested, varied 
from 7% (for 4-OH-ILE) to 24% (for TSW) of the total variation due to treatment. The 
main effect of G for DIOS accounted for 78% of the total variation (Table 4.2). Main 
effects of genotype and growing environment on the mean performance of the evaluated 
traits are given in Table 4.3. A Tukey’s Honestly Significant Difference (HSD) test was 
performed to separate treatment means, based on their statistical significance.  
 
4.1.1.1  Thousand seed weight 
 
  On average, the mean seed weight expressed as 1000-seed weight (TSW) 
significantly varied among genotypes with a range of 12.9 g for F75 to 17.6 g for AC 
Amber. AC Amber produced the heaviest seed among all the genotypes tested and the 
seed was also significantly heavier than all the genotypes tested (Table 4.3). The 
fenugreek genotype F75 produced the smallest seed in terms of mean seed weight and it 
was statistically comparable with those of F17 and Quatro MP 30. The TSW of Tristar 
was statistically comparable with those of Quatro MP 30, F17 and F86. TSW of L3312 
was statistically comparable with those of Ind Temp and F96. Moreover, TSW of F96 
was statistically comparable with those of X92 and Ind Temp with a range of 15.1 g
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Table 4.1 Mean squares for thousand seed weight, seed yield, galactomannan content and productivity, diosgenin content and 
productivity, and 4-hydroxyisoleucine content and productivity. 
 
 
Source of 
variation 
 
 
 
df 
Mean Squares 
 
TSW 
(g) 
 
SY 
(kg ha-1) 
 
GLM 
(%) 
 
GLM-P 
(kg ha-1) 
 
DIOS 
(%) 
 
DIOS-P 
(kg ha-1) 
 
4-OH-ILE 
(%) 
 
4-OH-Ile-P 
(kg ha-1) 
Replication within 
environment  14 2.9** 232122** 1.4NS 8780 ** 0.002NS 9.7** 0.049** 36.1** 
Environment (E) 13 113.7** 14360270** 97.1** 538377** 0.014** 512.0** 0.613** 813.9** 
Genotype (G) 9 61.4** 2540376** 21.6** 105739** 0.247** 79.5** 0.084** 206.1** 
G x E 117 2.7** 311964* 2.9** 12358** 0.003** 11.4** 0.012** 21.6** 
Error 126 0.8 91914 1.4 2944 0.001 4.0 0.007 6.8 
Coefficient of variation (%) 6.0 20.8 7.3 21.7 6.6 22.5 9.1 20.3 
** Denotes significance at p  0.01, NS Not significant at p = 0.05, df, degrees of freedom, TSW, thousand seed weight; SY, seed 
yield; GLM, galactomannan content; GLM-P; galactomannan productivity; DIOS, diosgenin content; DIOS-P, diosgenin productivity; 
4-OH-ILE, 4-hydroxyisoleucine content; 4-OH-ILE-P, 4-hydroxyisoleucine productivity.
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Table 4.2 Contribution of genotype, environment and genotype x environment 
effects to the total variance due to treatments observed for 8 selected traits 
evaluated in this study. 
Source of variation Sum of Squares (SS) SS (%) 
Thousand Seed Weight (g) 
E 1478 63 
G 552 24 
G x E 318 14 
Total  2348 100 
   
Seed Yield (kg ha-1) 
E 186683514 76 
G 22863390 9 
G x E 36499818 15 
Total 246046722 100 
   
Galactomannan Content (%)
E 1263 70 
G 195 11 
G x E 350 19 
Total 1807 100 
   
Galactomannan Productivity (kg ha-1)
E 6998901 74 
G 951649 10 
G x E 1445876 15 
Total 9396426 100 
   
Diosgenin Content (%) 
E 0.18 6 
G 2.23 78 
G x E 0.45 16 
Total 2.86 100 
   
Diosgenin Productivity (kg ha-1)
E 6657 77 
G 716 8 
G x E 1329 15 
Total 8701 100 
   
4-Hydroxyisoleucine Content (%)
E 7.98 78 
G 0.76 7 
G x E 1.51 15 
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Total 10.25 100 
 
4-Hydroxyisoleucine Productivity (kg ha-1)  
E 10580 71 
G 1855 12 
G x E 2527 17 
Total 14962 100 
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Table 4.3 Main effects of genotype and growing environment on the mean performance of 8 selected traits of fenugreek grown 
in southern Alberta. 
 Traits 
 
TSW 
(g) 
SY 
(kg ha-1) 
GLM 
(%) 
GLM-P 
(kg ha-1) 
DIOS 
(%) 
DIOS-P 
(kg ha-1) 
4-OH-ILE 
(%) 
4-OH-ILE-P 
(kg ha-1) 
Genotype         
 Tristar 13.7bc 1586bc 16.6def 277.0b 0.53ab 8.4bc 0.99d 14.7de
 Quatro MP 30 13.1ab 1733bc 16.5cdef 301.5bc 0.66e 11.6e 0.91abc 14.8de
 AC Amber 17.6g 1198a 14.6a 186.1a 0.81g 9.8cd 0.95bcd 10.5ab
 F17 13.0ab 1541b 16.9def 272.4b 0.50a 7.5ab 0.92abcd 13.7cd
 F96 15.1ef 1617bc 15.6abc 265.1b 0.61d 9.7cd 0.88ab 13.0cd
 F75 12.9a 1814c 17.6f 324.8c 0.59cd 10.9de 0.98cd 16.6e
 X92 15.7f 995a 16.1bcd 164.1a 0.75f 7.6ab 0.85a 8.3a
 Indian Temple 15.3ef 959a 15.5ab 150.7a 0.62d 5.9a 0.99d 8.7a
 L3312 14.7de 1620bc 17.1ef 295.7bc 0.53ab 8.6bc 0.90ab 13.8cd
 F86 14.0cd 1547b 16.3bcde 265.2b 0.57bc 8.8bc 0.85a 12.0bc
Critical value, q 0.74 256.11 1.01 45.84 0.03 1.69 0.07 2.21 
Environment         
 BR-Irr-06 14.7e 2722g 17.4fgh 475.3g 0.57a 15.3g 0.83cd 23.7g 
 BR-Dry-06 17.4f 3102h 18.2h 573.2h 0.64cde 19.3h 0.81bc 25.6g 
 BI-Irr-06 15.0e 2407f 17.9gh 442.8g 0.59ab 14.0g 0.84cd 20.4f 
 BI-Dry-06 13.5c 1599e 21.5i 344.9f 0.66de 10.6f 0.68a 11.5cde 
 LB1-Irr-06 14.5de 772b 15.5cd 120.1bcd 0.62bcd 4.8bc 0.81bc 6.6ab 
 LB1-Dry-06 17.4f 1438de 17.0efgh 247.3e 0.67e 9.5f 0.91de 13.6e 
 BR-Irr-07 11.9a 1157cd 13.6ab 156.9cd 0.59ab 6.8cde 0.88cd 10.3cd 
 BR-Dry-07 12.9bc 365a 12.8a 46.8a 0.60abc 2.2a 1.26i 4.6a 
 BI-Irr-07 17.6fg 2209f 16.1de 356.9f 0.62bcd 13.4g 0.82c 18.3f 
 BI-Dry-07 12.3ab 1390de 16.9efg 236.3e 0.62bcd 8.5ef 0.73ab 10.2cd 
 LB1-Irr-07 18.5g 873bc 16.2def 142.5bcd 0.63bcde 5.4bcd 1.04fg 9.2bc 
 LB1-Dry-07 12.2ab 604ab 15.4cd 92.8ab 0.61abc 3.6ab 1.20hi 7.2ab 
 LB2-Irr-07 13.6cd 1143cd 14.5bc 167.0d 0.62bcd 7.0de 1.12gh 12.7de 
 LB2-Dry-07 11.4a 671ab 15.0cd 100.7abc 0.59ab 4.0ab 0.98ef 6.6ab 
Critical value, q 0.92 321.33 1.26 57.51 0.04 2.12 0.09 2.77 
                                                 
 TSW, thousand seed weight; SY, seed yield; GLM, galactomannan content; GLM-P; galactomannan productivity; DIOS, diosgenin content; DIOS-P, diosgenin productivity; 4-OH-ILE, 4-
hydroxyisoleucine content; 4-OH-ILE-P, 4-hydroxyisoleucine productivity. Means that share similar superscripts within the same column under either genotype main effect or environment main effect 
are not significantly different from each other (Tukey’s HSD at p ≤ 0.05).   
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to 15.7 g, which represents a heavy seed category among the tested genotypes. AC 
Amber produced the heaviest seed among all the genotypes tested, and TSW of AC 
Amber was significantly higher than those of all the tested fenugreek genotypes.  
On average, TSW among environments varied significantly with a range of 11.4 
g (for LB2-Dry-07) to 18.5 g for (LB1-Irr-07). The growing environment LB2-Dry-07 
produced the smallest mean seed weight, but it was statistically comparable with the 
TSW observed at BR-Irr-07, BI-Dry-07 and LB1-Dry-07. TSW observed at LB1-Irr-07 
was statistically comparable with that of BI-Irr-07. TSW observed at BR-Dry-07 was 
statistically comparable to that of LB2-IR-07, but it was significantly lower than those of 
BR-Irr-06, BR-Dry-06, BI-Irr-06, LB1-Irr-06 and BI-Irr-07.  
 
4.1.1.2 Seed yield 
 
On average, fenugreek genotypes evaluated under various growing 
environments in southern Alberta produced significantly different (p < 0.01) seed yields 
(SY) with a range of 959 kg ha-1 for Ind Temp to 1814 kg ha-1 for F75 (Table 4.3). SY of 
F75 was statistically comparable to those of Tristar, Quatro MP 30, F96, and L3312. SY 
of Ind Temp was statistically comparable to those of X92 (995 kg ha-1) and AC Amber 
(1198 kg ha-1).  
SY among environments varied significantly with a range from 365 kg ha-1 for 
BR-Dry-07 to 3102 kg ha-1 for BR-Dry-06 (Table 3.3). Both BR-Irr-06 (2722 kg ha-1) and 
BR-Dry-06 (3102 kg ha-1) produced the highest SY among all environments and were 
found to be significantly higher than those observed at all the other growing 
environments tested. SY at BR-Dry-07 was statistically comparable to that of LB1-Dry-
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07 (604 kg ha-1) and LB2-Dry-07 (671 kg ha-1). LB1-Dry-06, BR-Irr-07, BI-Dry-07 and 
LB2-Irr-07 (1143 – 1438 kg ha-1) produced statistically comparable SY but they were 
significantly lower than those of BI-Irr-07 (2209 kg ha-1) and BI-Irr-06 (2407 kg ha-1).  
 
4.1.1.3 Galactomannan content 
 
 On average, the seed galactomannan content of fenugreek genotypes varied 
significantly (p ≤ 0.01) with a range of 14.6 % for AC Amber to 17.6 % for F75 (Table 
4.3). F75 produced the highest GLM among the genotypes tested and it was statistically 
comparable to that of Tristar, Quatro MP 30, F17 and L3312, with a range of 16.5 % to 
17.1 %. The GLM of AC Amber was statistically comparable with that of Ind Temp and 
F96, but was significantly lower than those of X92 and F86.  
On average, the GLM content among growing environments significantly 
varied with a range of 12.8 % for Br-Dry-07 to 12.5 % for BI-Dry-06 (Table 4.3). The 
GLM at BI-Dry-06 was significantly higher than those of all the other growing 
environments tested. The GLM observed at LB1-Irr-06 (15.5 %) was statistically 
comparable with those observed at BI-Irr-07, LB1-Irr-07, LB1-Dry-07 and LB2-Dry-07, 
within a range of 15.0 % to 16.2 %. BR-Irr-06, BR-Dry 06, BI-Irr-06 and LB1-Dry-06 
produced statistically comparable GLM with a range of 17.0 % to 18.2 % (Table 4.3). 
 
4.1.1.4 Galactomannan productivity 
 
 Galactomannan productivity (GLM-P) was calculated by multiplying SY by 
GLM. On average, GLM-P of fenugreek genotypes tested varied significantly with a 
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range of 150.7 kg ha-1 for Ind Temp to 324.8 kg ha-1 for F75. The GLM-P of Ind Temp 
was statistically comparable to that of AC Amber and X92. Genotypes Tristar, F17, F96 
and F86 reported statistically comparable GLM-P, ranging from 265.1 kg ha-1 to 277.0 kg 
ha-1, while GLM-P reported for Quatro MP 30 and L3312 were statistically comparable 
to that of F75.  
The GLM-P among growing environments significantly varied with a range of 
46.8 kg ha-1 for BR-Dry-07 to 573.2 kg ha-1 for BR-Dry-06. The GLM-P observed at 
LB1-Irr-06 was statistically comparable with those observed at BR-Irr-07, LB1-Irr-07 
and LB2-Dry-07, with a range of 100.7 kg ha-1 to 156.9 kg ha-1. The GLM-P observed at 
LB1-Dry-06 was statistically comparable with that observed at BI-Dry-07. The GLM-P 
observed at BI-Dry-06 was comparable with that observed at BI-Irr-07. On average, BR-
Irr-06 and BI-Irr-06 observed statistically comparable GLM-P, ranging from  
442.8 kg ha-1 to 475.3 kg ha-1 but these were significantly lower than that observed at 
BR-Dry-06 at 573.2 kg ha-1. 
 
4.1.1.5 Diosgenin content 
 
On average, DIOS of seeds among the ten fenugreek genotypes varied 
significantly with a range of 0.50 % for F17 to 0.81 % for AC Amber (Table 4.3). DIOS 
of Tristar was statistically comparable to those of F17, L3312 and F86, within a range of 
0.50 % to 0.57%. Genotypes F96, F75 and Ind Temp produced comparable DIOS but 
these were significantly lower than those of Quatro MP 30, AC Amber and X92.  
On average, a relatively narrow variation in DIOS was observed among 
environments, with a range of 0.57 % to 0.67 % (Table 4.3). BR-Irr-06, on average, 
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produced seed with the lowest DIOS, although this was statistically comparable to DIOS 
observed at BI-Irr-06, BR-Irr-07, BR-Dry-07, LB1-Dry-07 and LB2-Dry-07. On average, 
the environments Br-Dry-06, LB1-Irr-06, BR-Dry-07, BI-Irr-07, BI-Dry-07, LB1-Irr-07, 
LB1-Dry-07 and LB2-Irr-07 produced statistically comparable DIOS within a range of 
0.60 % to 0.64 %. The environment LB1-Dry-06 on average produced the highest DIOS, 
although this was also statistically comparable to those observed at BR-Dry-06 and BI-
Dry-06. 
 
4.1.1.6 Diosgenin productivity 
 
Diosgenin productivity (DIOS-P) was calculated by multiplying SY by DIOS. 
On average, DIOS-P among genotypes significantly varied with a range 5.9 kg ha-1 for 
Ind Temp to 11.6 kg ha-1 for Quatro MP 30 (Table 4.3). The DIOS-P for Ind Temp was 
statistically comparable to those of F17 and X92, with a range of 5.9 kg ha-1 to  
7.6 kg ha-1.  The DIOS-P of Tristar (8.4 kg ha-1) was statistically comparable to those of 
L3312, F86, AC Amber and F96, but was significantly lower than those of F75 and 
Quatro MP 30.   
On average, a larger variation was observed for DIOS-P among environments, 
with a range of 2.2 kg ha-1 to 19.3 kg ha-1 for BR-Dry-07 and BR-Dry 06, respectively. 
DIOS-P observed at BR-Dry-07 was statistically comparable to those of LB1-Dry-07 and 
LB2-Dry-07, but was significantly lower than that of LB1-Irr-06 (4.8 kg ha-1) and LB1-
Irr-07 (5.4 kg ha-1). BI-Dry-06, LB1-Dry-06 and BI-Dry-07 reported comparable DIOS-
P, within a range of 8.5 kg ha-1 to 10.6 kg ha-1. The DIOS-P observed at BI-Dry-07, BI-
Irr-06 and BR-Irr-06 were statistically comparable, ranging from 13.4 kg ha-1 to 15.3 kg 
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ha-1. However, these values were significantly lower than that observed at BR-Dry-06 
(19.3 kg ha-1).  
 
4.1.1.7  4-Hydroxyisoleucine content 
 
The 4-OH-ILE of fenugreek genotypes varied significantly with a range of 
0.85% to 0.99% (Table 4.3). 4-OH-ILE observed in genotypes X92, F86, F96, L3312, 
Quatro MP 30 and F17 was statistically comparable, ranging from 0.85 % to 0.92 % 
(Table 4.3). 4-OH-ILE observed in AC Amber was comparable to that of F75, Tristar and 
Ind Temp (0.99 %).  
A larger variation in 4-OH-ILE was observed among environments, ranging 
from 0.68 % to 1.26 % for BR-Dry-07 and BI-Dry-06, respectively (Table 4.3). Within a 
range of 0.81 % to 0.88 %, the 4-OH-ILE observed at BR-Dry-06, BR-Irr-06, BI-Irr-06, 
LB1-Irr-06, BR-Irr-07 and BI-Irr-07 were statistically comparable. On average, 4-OH-
ILE observed at LB1-Dry-06 (0.91 %) was comparable to that of LB2-Dry-07 (0.98 %) 
but was significantly lower than that of LB1-Irr-07 (1.04 %). The 4-OH-ILE observed at 
LB2-Irr-07 (1.12 %) was comparable to that observed at LB1-Dry-07 (1.20 %), but was 
significantly lower that observed at BR-Dry-07 (1.26 %). While rainfed growing 
environments such as BR-Dry-07 and LB1-Dry-07 produced low SY at 365 kg ha-1 and 
604 kg ha-1, respectively (Table 4.3), relatively higher 4-OH-ILE (1.20-1.26 %) was 
observed when compared to the other environments tested (Table 4.3).   
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4.1.1.8 4-Hydroxyisoleucine productivity  
 
4-Hydroxyisoleucine productivity (4-OH-ILE-P) was calculated by 
multiplying SY by 4-OH-ILE. On average, the 4-OH-ILE-P among fenugreek genotypes 
varied significantly with a range of 8.3 kg ha-1 for X92 to 16.6 kg ha-1 for F75 (Table 4.3). 
The 4-OH-ILE-P for X92, Ind Temp and AC Amber were statistically comparable falling 
within a range of 8.3 kg ha-1 to 10.5 kg ha-1. At, 4-OH-ILE-P for the F86 (12.0 kg ha-1) 
was comparable to that of F96, F17 and L3312 (Table 3.3). 4-OH-ILE-P was highest in 
F75, and it was statistically comparable to that of Tristar and Quatro MP 30 at 14.7 kg ha-
1 and 14.8 kg ha-1, respectively.  
A greater variation in 4-OH-ILE-P was observed among environments with a 
range of 4.6 kg ha-1 to 25.6 kg ha-1 (Table 4.3). The 4-OH-ILE-P observed at BR-Dry-07 
was statistically comparable to those observed at LB1-Irr-06, LB1-Dry-07 and LB2-Dry-
07, ranging from 4.6 kg ha-1 to 7.2 kg ha-1. LB1-Irr-07 produced 9.2 kg ha-1, which was 
comparable to those of BI-Dry-07, BR-Irr-07, and BI-Dry-06, but was significantly lower 
than that of LB2-Irr-07 (12.7 kg ha-1). The 4-OH-ILE-P observed at BI-Irr-07 (18.3 kg 
ha-1) was comparable to that of BI-Irr-06 (20.4 kg ha-1), but was significantly lower than 
that observed at BR-Irr-06 (23.7 kg ha-1) and BR-Dry-06 (26.5 kg ha-1). 
 
4.1.2  Genotype x environment interaction effects  
 
Although the G x E interaction effect contributed only 14-19 % (Table 4.2) the 
total variation observed for each of the eight selected agronomic and biochemical traits, 
it is still considered significant as further analysis of this component would provide 
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statistical information to rank and group genotypes, based on performance under 
different growing environments.  
An Agglomerative Hierarchical Cluster analysis (XLSTAT, Addinsoft, New 
York, NY) was carried out on means of selected traits of fenugreek genotypes grown 
across 14 environments (Fig 4.1). Response analysis indicated that GLM-P, SY and 4-
OH-ILE-P are closely associated to each other (r > 0.92), whereas DIOS and TSW were 
weakly associated to each other (r > 0.72). In general, the analysis produced three distinct 
clusters; where GLM-P, SY, 4-OH-ILE-P and GLM formed a cluster, DIOS and TSW 
formed another cluster, and 4-OH-ILE was too different to be shared by any one cluster, 
and hence formed a cluster on its own (Fig. 4.1).   
The genotype x environment interaction effects for eight agronomic and 
biochemical traits evaluated in this study were further analyzed using the GGE biplot 
methodology (Yan, 1999). The “which won what” view of the biplot identifies the 
winning genotypes for each of the selected agronomic and biochemical traits as indicated 
by the vertices of the polygon. Perpendicular lines originating from the biplot origin 
divide the polygon into sections containing winning genotypes with their corresponding 
traits. Based on performance, F75 was the most promising genotype in terms of SY, 
GLM-P and 4-OH-ILE-P, and F17 was the best performing for 4-OH-ILE (Fig. 4.2). 
Although genotype AC Amber was the best performer in terms of DIOS, genotype 
Quatro MP 30 was better in terms of DIOS-P, as a result of its high seed yielding 
capacity. Other genotypes located within the polygon were not as discriminatory for the 
traits studied (Fig 4.2). 
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Figure 4.1 Dendrogram depicting hierarchical clustering of the 8 traits based on the 
means of 10 fenugreek genotypes tested across 14 growing environments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                                                 
 Similarity of clusters is based on Pearson correlation coefficients; agglomeration of the 
clusters based on unweighted pair-group average. Similar color groups represent distinct 
clusters. Dotted line represent truncation point for clusters. TSW = 1000-seed weight; SY 
= seed yield; GLM = galactomannan content; GLM-P = galactomannan productivity; 
DIOS = diosgenin; DIOS-P = diosgenin productivity; 4-OH-ILE = 4-hydroxyisoleucine; 
4-OH-ILE-P = 4-hydroxyisoleucine productivity. 
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 4-OH-ILE-P 
GLM-P 
 
 
Figure 4.2 The "which won what" view of the “genotype x trait” GGE biplot 
for all 8 traits of 10 fenugreek genotypes tested across 14 environments. 
                                                 
 Traits parameters are in uppercase and genotypes are in lower case. PC 1 and PC 2 are 
primary and secondary effects, respectively. TSW = 1000-seed weight; SY = seed yield; 
GLM = galactomannan content; GLM-P = galactomannan productivity; DIOS = 
diosgenin content; DIOS-P = diosgenin productivity; 4-OH-ILE = 4-hydroxyisoleucine; 
4-OH-ILE-P = 4-hydroxyisoleucine productivity. 
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4.1.2.1 Thousand seed weight 
 
The G x E interaction effect for TSW accounted for 14% of the total variation 
due to treatments (Table 4.2). The interaction effect for TSW due to treatments is 
graphically represented in a scatter diagram (Fig. 4.3; for numerical values, see Appendix 
II). Performance-stable genotypes should theoretically produce parallel lines (lack of 
cross-overs) when plotted against the growing environments in the absence of a G x E 
interaction. Even though the growing environments are discrete variables, lines drawn 
connecting the data points are intended to exhibit the crossover interactions. Among the 
genotypes tested, only genotype AC Amber demonstrated fairly good stability, almost 
always ranking first in terms of TSW (few cross-overs) (Fig. 4.3).  
Hierarchical clustering of genotypes according to their response patterns in 
terms of TSW is presented in a dendogram in Fig. 4.4. The hierarchical cluster analysis  
indicates that genotypes F96, Tristar, F75, Quatro MP 30, F86, F17 and L3312 have 
formed one cluster, generally representing smaller seed weights. AC Amber and X92, 
which had larger seed weights, together form a distinct cluster while Ind Temp remained 
in a cluster on its own (Fig. 4.4).   
The GGE biplot analysis on TSW is presented in Fig. 4.5, in a “which won 
where” view. The analysis shows that TSW was most responsive in Ind Temp, F75, 
Quatro MP 30, F96 and AC Amber, given their position at the vertices of the polygon. 
However, the location of F75 at the farthest left of the polygon (low PC 1 score) indicates 
poor performance (low yielding) while AC Amber located at the farthest right of the 
polygon (high PC 1 score), surrounded by the majority of growing environments 
indicates superior performance (a winning genotype) in those environments [2 (BR-Dry-
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Figure 4.3 A scatter plot of mean thousand seed weight (g) and growing environments (numbered 1 to 14) to illustrate the 
presence of genotype x environment interaction for 10 fenugreek genotypes tested across 14 environments in southern 
Alberta.
                                                 
 Environment 1 = BR-Irr-06; 2 = BR-Dry-06; 3 = BI-Irr-06; 4 = BI-Dry-06; 5 = LB1-Irr-06; 6 = LB1-Dry-06; 7 = BR-Irr-07; 8 = BR-Dry-07; 9 = BI-Irr-07; 10 
= BI-Dry-07; 11 = LB1-Irr-07; 12 = LB1-Dry-07; 13 = LB2-Irr-07; 14 = LB2-Dry-07.  
Note: Environments are considered discrete variables, lines drawn connecting the data points are intended to exhibit the crossover interactions. 
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Figure 4.4 Dendogram depicting the hierarchical clustering of 10 fenugreek 
genotypes tested in 14 environments according to thousand seed weight (g). 
                                                 
 Similarity of clusters is based on Pearson correlation coefficients; agglomeration of the 
clusters based on unweighted pair-group average. Similar color groups represent a 
distinct cluster. The dotted line represents the truncation point for clusters. 
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Figure 4.5 The “which won where” view of the GGE biplot for mean thousand seed 
weight (g) of 10 fenugreek genotypes tested across 14 growing environments. 
                                                 
 PC 1 denotes Principal Component 1, and PC 2 denotes Principal Component 2. 
Genotypes are in blue, growing environments are numbered 1 to 14, in red. 
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06), 4 (BI-Dry-06), 6 (LB1-Dry-06), 10 (BI-Dry-07), 12 (LB1-Dry-07), 13 (LB2-
Irr-07), 14 (LB2-Dry-07)]. The TSW trait was fairly stable in these environments, 
as indicated by the low PC 2 scores (small deviation from PC 2 axis), with the 
exception of Ind Temp, which had the greatest deviation on the PC 2 axis (Fig. 
4.5). 
 
4.1.2.2 Seed yield 
 
The main effect of growing environment for SY contributed 76 % to the 
total variation due to treatment, while the main genotypic effect contributed only 
a mere 9% (Table 4.2). Moreover, the G x E interaction effect was higher than 
that of genotype at 
 15 %. The G x E interaction effect for SY is graphically represented in Fig. 4.6. 
A scatter diagram of SY was plotted against environments (Fig. 4.6; for numerical 
values see Appendix II) to illustrate the crossover interaction characteristic of 
these multi-environment trials, where ranking of genotypes in terms of 
productivity changed across environments. In this analysis, genotypes with higher 
seed yield stability should theoretically produce parallel lines across environments, 
suggesting a lack of interaction with the environment. Even though growing 
environments are considered discrete variables, lines drawn connecting the data 
points are intended to exhibit the crossover interactions. SY assessed over the 
different environments tested produced significant crossover (i.e. F86) and 
changes in genotype rankings (Fig. 4.6); indicating the presence of a G x E 
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interaction. In contrast, genotypes X92 and Ind Temp were shown to be 
consistently low-yielding (stable).  
The hierarchical cluster analysis of genotype for SY was performed to 
group genotypes based on similarities in their genotype response pattern (Fig. 
4.7). This analysis indicates that F75, Quatro MP 30, F96, L3312 and Tristar have 
formed one cluster whereas F17, AC Amber, F86, Ind Temp and X92 formed 
distinct and separate clusters; i.e., each remained in a cluster on its own.  
The GGE biplot analysis on SY (Fig. 4.8) shows the most responsive 
genotypes (F17, X92, F86 and F75) based on their locations at the vertices of the 
polygon, and the most discriminating environments [1 (BR-Irr-06), 2 (BR-Dry-
06), 3 (BI-Irr-06) and 9 (BI-Irr-07)], given their furthest distances from the biplot 
origin. F75 is identified as possessing the best performing genotype based on its 
high PC 1 score (located furthest right) while X92 was the lowest seed yielding 
genotype with the lowest PC 1 score (located furthest left). However, these 
genotypes were considered stable (consistent performance) as their PC 2 scores 
were close to zero.  
 
 
 
4.1.2.3 Galactomannan content 
 
The G x E interaction effect on GLM accounted for 19 % of the 
variation, due to treatments (Table 4.2) .The interaction effect on GLM is 
graphically represented in Fig. 4.9. A scatter diagram of GLM was plotted against 
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Figure 4.6 A scatter plot of mean seed yield (kg ha-1) and growing environments (numbered 1 to 14) to illustrate the presence 
of genotype x environment interaction for 10 fenugreek genotypes tested across 14 environments in southern Alberta. 
                                                 
 1 = BR-Irr-06; 2 = BR-Dry-06; 3 = BI-Irr-06; 4 = BI-Dry-06; 5 = LB1-Irr-06; 6 = LB1-Dry-06; 7 = BR-Irr-07; 8 = BR-Dry-07; 9 = BI-Irr-07; 10 = BI-Dry-07; 
11 = LB1-Irr-07; 12 = LB1-Dry-07; 13 = LB2-Irr-07; 14 = LB2-Dry-07.  
Note: Environments are considered discrete variables, lines drawn connecting the data points are intended to exhibit the crossover interactions. 
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Figure 4.7 Dendogram depicting the hierarchical clustering of 10 fenugreek 
genotypes tested in 14 environments based on their mean seed yield (kg ha-1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
 Similarity of clusters is based on Pearson correlation coefficients; agglomeration of the 
clusters based on unweighted pair-group average. Similar color groups represent a 
distinct cluster. The dotted line represents the truncation point for clusters. 
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Figure 4.8 The “which won where” view of the GGE biplot for mean seed yield 
(kg ha-1) of 10 fenugreek genotypes tested across 14 environments.   
 
                                                 
 PC 1 denotes Principal Component 1 and PC 2 denotes Principal Component 2. 
Genotypes are in blue, growing environments are numbered 1 to 14, in red. 
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the growing environments (Fig. 4.9; for numerical values see Appendix II).  
Significant crossover was observed among genotypes as response to the growing 
environments in terms of GLM. F75 and AC Amber were observed to produce fewer 
crossovers among the genotypes tested. Even though growing environments are 
considered discrete variables, lines drawn connecting the data points are intended to 
exhibit the crossover interactions. 
 Hierarchical cluster analysis performed for GLM indicates that genotypes F96, 
Tristar, X92 and Quatro MP 30 have formed one cluster, and L3312, F17 and Ind Temp 
formed another cluster. AC Amber, F75 and F86 were too different in their response 
patterns to share any one cluster (Fig. 4.10).  
The GGE biplot analysis for GLM determined that the most responsive 
genotypes were AC Amber, L3312, F75 and F86, based on their positions at the vertices 
of the polygon (Fig. 4.11). The most favorable environments for F75 to produce higher 
GLM include 4 (BI-Dry-06), 6 (LB1-Dry-06), 3 (BI-Irr-06), 10 (BI-Dry-07), 7 (BR-Irr-
07), 14 (LB2-Dry-07) and 13 (LB2-Irr-07), all located at the top right sector of the biplot 
(Fig. 4.11). AC Amber was the poorest performing genotype in terms of GLM given its 
low PC 1 score but was also the most stable (low PC 2 score) among the responsive 
genotypes.  
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Figure 4.9 A scatter plot of galactomannan content (%) and growing environments (numbered 1 to 14) to illustrate the 
presence of genotype x environment interaction for 10 fenugreek genotypes tested across 14 environments in southern 
Alberta. 
                                                 
 Environment 1 = BR-Irr-06; 2 = BR-Dry-06; 3 = BI-Irr-06; 4 = BI-Dry-06; 5 = LB1-Irr-06; 6 = LB1-Dry-06; 7 = BR-Irr-07; 8 = BR-Dry-07; 9 = BI-Irr-07; 10 
= BI-Dry-07; 11 = LB1-Irr-07; 12 = LB1-Dry-07; 13 = LB2-Irr-07; 14 = LB2-Dry-07.  
Note: Environments are considered discrete variables, lines drawn connecting the data points are intended to exhibit the crossover interactions. 
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Figure 4.10 Dendogram depicting the hierarchical clustering of 10 fenugreek 
genotypes tested in 14 environments based on their mean galactomannan 
content(%). 
 
 
 
 
 
 
 
 
 
 
 
                                                 
 Similarity of clusters is based on Pearson correlation coefficients; agglomeration of the 
clusters based on unweighted pair-group average. Similar color groups represent a distinct 
cluster. The dotted line represents the truncation point for clusters. 
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Figure 4.11 The  GGE biplot for mean galactomannan content (%) of 10 fenugreek 
genotypes tested across 14 environments.  
                                                 
 PC 1 denotes Principal Component 1 and PC 2 denotes Principal Component 2. 
Genotypes are in blue, growing environments are numbered 1 to 14, in red. 
1 = BR-Irr-06 
2 = BR-Dry-06 
3 = BI-Irr-06 
4 = BI-Dry-06 
5 = LB1-Irr-06 
6 = LB1-Dry-06 
7 = BR-Irr-07 
8 = BR-Dry-07 
9 = BI-Irr-07 
10 = BI-Dry-07 
11 = LB1-Irr-07 
12 = LB1-Dry-07 
13 = LB2-Irr-07 
14 = LB2-Dry-07 
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4.1.2.4 Galactomannan productivity 
 
The G x E interaction effect on galactomannan productivity (GLM-P) accounted 
for 15% of the total variation observed due to treatments (Table 4.2). For the numerical 
values representing the interaction effect on GLM-P, see Appendix II. 
The GGE biplot analysis shows that genotypes F86, Ind Temp, X92, AC Amber, 
F17 and F75 were the most responsive genotypes in terms of GLM-P, as indicated by their 
positions at the vertices of the polygon (Fig. 4.12). Results show that F75 was the best 
performing genotype, as it is situated on the furthest right of the biplot (high PC 1 score).  2 
(BR-Dry-06) was the most discriminative environment for F75, given its location furthest 
away from the biplot origin inside its sector. Similarly, 1 (BR-Irr-06) and 3 (BI-Irr-06)  
were the best environments for F86, indicated by their locations furthest away from the 
biplot origin within the F86 sector.  
 
 
4.1.2.5 Diosgenin content 
 
The G x E interaction effect on diosgenin content (DIOS) contributed 16 % of 
the total variation due to treatments (Table 4.2). The interaction effect on DIOS of the 
fenugreek genotypes is graphically represented in Fig. 4.13. Even though the environments 
are considered discrete variables, lines drawn connecting the data points are intended to 
exhibit the crossover interactions. The scatter plot shows crossover interactions among 
genotypes across growing environments for DIOS (Fig. 4.13; for numerical values see 
Appendix II). However, this change was relatively subtle compared to the crossover 
interactions observed for other traits as indicated in Figs. 4.3, 4.6, 4.9. Among the  
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Figure 4.12 The "which won where" view of the GGE biplot for mean galactomannan 
productivity (kg ha-1) of 10 fenugreek genotypes testedacross 14 environments. 
                                                 
 PC 1 denotes Principal Component 1 and PC 2 denotes Principal Component 2. 
Genotypes are in blue, growing environments are numbered 1 to 14, in red. 
1 = BR-Irr-06 
2 = BR-Dry-06 
3 = BI-Irr-06 
4 = BI-Dry-06 
5 = LB1-Irr-06 
6 = LB1-Dry-06 
7 = BR-Irr-07 
8 = BR-Dry-07 
9 = BI-Irr-07 
10 = BI-Dry-07 
11 = LB1-Irr-07 
12 = LB1-Dry-07 
13 = LB2-Irr-07 
14 = LB2-Dry-07 
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Figure 4.13 A scatter plot of mean diosgenin content (%) and growing environments (numbered 1 to 14) to illustrate the 
presence of genotype x environment interaction for 10 fenugreek genotypes tested across 14 environments in southern 
Alberta. 
                                                 
 Environment 1 = BR-Irr-06; 2 = BR-Dry-06; 3 = BI-Irr-06; 4 = BI-Dry-06; 5 = LB1-Irr-06; 6 = LB1-Dry-06; 7 = BR-Irr-07; 8 = BR-Dry-07; 9 = BI-Irr-07; 10 
= BI-Dry-07; 11 = LB1-Irr-07; 12 = LB1-Dry-07; 13 = LB2-Irr-07; 14 = LB2-Dry-07.  
Note: Environments are considered discrete variables, lines drawn connecting the data points are intended to exhibit the crossover interactions. 
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genotypes tested, AC Amber and X92 which observed high DIOS also had minimal 
crossover interactions across growing environments suggesting that these genotypes not 
only had high diosgenin-producing capacity but also good stability.  
Hierarchical cluster analysis performed for DIOS of fenugreek genotypes 
showed that F86 and Tristar have formed one cluster, while Ind Temp, X92, AC Amber, 
and L3312 have formed another cluster. F96, F75, Quatro MP 30 and F17 were too 
different from each other in their response patterns to consider placing them in the same 
cluster; hence they were placed in individual clusters (Fig. 4.14).  
The GGE biplot analysis shows AC Amber and X92 as the most promising 
genotypes in terms of DIOS in all growing environments except at 12 (LB1-Dry-07), 
indicated by their high PC 1 scores and close proximity to all but one environment within 
the sector (Fig. 4.15). Although AC Amber was superior to X92 in terms of DIOS, the 
lower PC 2 score of X92 indicates better stability (consistency) compared to that of AC 
Amber (Fig 4.15). 
 
 
4.1.2.6 Diosgenin productivity 
 
Diosgenin productivity (DIOS-P) was similar to the trend exhibited by SY; i.e., 
77 % of the total variation for DIOS-P was attributed to the environment main effect 
while only 8 % of the total variation was contributed by the genotype main effect (Table 
4.2). The remaining 15 % of the variation was attributed to the G x E interaction effect. 
For numerical values representing the G x E interaction for DIOS-P, see Appendix II.  
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Figure 4.14 Dendogram depicting the hierarchical clustering of 10 fenugreek 
genotypes tested in 14 environments based on their mean diosgenin content (%). 
 
 
 
 
 
 
 
 
 
 
                                                 
 Similarity of clusters is based on Pearson correlation coefficients; agglomeration of the 
clusters based on unweighted pair-group average. Similar color groups represent a 
distinct cluster. The dotted line represents the truncation point for clusters. 
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Figure 4.15 The "which won where" view of the GGE biplot for mean diosgenin 
content (%) of 10 fenugreek genotypes tested across 14 environments.  
 
                                                 
 PC 1 denotes Principal Component 1 and PC 2 denotes Principal Component 2. 
Genotypes are in blue, growing environments are numbered 1 to 14, in red. 
1 = BR-Irr-06 
2 = BR-Dry-06 
3 = BI-Irr-06 
4 = BI-Dry-06 
5 = LB1-Irr-06 
6 = LB1-Dry-06 
7 = BR-Irr-07 
8 = BR-Dry-07 
9 = BI-Irr-07 
10 = BI-Dry-07 
11 = LB1-Irr-07 
12 = LB1-Dry-07 
13 = LB2-Irr-07 
14 = LB2-Dry-07 
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 The GGE biplot analysis performed for DIOS-P identified F86, Ind Temp, AC 
Amber, Quatro MP 30 and F75 as the most responsive genotypes given their positions at 
the vertices of the polygon (Fig. 4.16). Most environments except for Br-Irr-06 (1), BI-
Irr-06 (3), Br-Dry-06 (2) and BI-Irr-07 (9) were not discriminative of the genotypes; i.e., 
most environments on the biplot are seen in close proximity to the origin (Fig. 4.16). F75 
was most promising genotype at Br-Irr-06 and BI-Irr-06 while Quatro MP 30 was the 
best performing genotype at all environments positioned within its sector; this excludes 1 
(BR-Irr-06), 3 (BI-Irr-06) and 14 (LB2-Dry-07).  Although Quatro MP 30 was superior to 
F75 in terms of DIOS-P, F75 was shown to be relatively more stable as indicated by its 
lower PC 2 score compared to that of Quatro MP 30 (Fig 4.16).   
 
 
 
4.1.2.7 4-Hydroxyisoleucine content 
 
The G x E interaction effect on 4-hydroxyisolecine content (4-OH-ILE) 
accounted for 15 % of the total variation observed (Table 4.2). The interaction effect is 
graphically represented in Fig. 4.17. Even though growing environments are considered 
discrete variables, lines drawn connecting the data points are intended to exhibit the 
crossover interactions. The presence of an interaction between genotypes and the growing 
environments for seed 4-OH-ILE was indicated by the extensive change in genotype 
rankings (crossovers) across environments (Fig. 4.17; for numerical values see Appendix 
II). While crossovers for the other genotypes may not be clearly observed, Ind Temp can 
be seen to demonstrate poor stability, indicated by its significant change in ranking in 
terms of 4-OH-ILE (Fig 4.17). 
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Figure 4.16 The "which won where" view of the GGE biplot for mean diosgenin 
productivity (kg ha-1) of 10 fenugreek genotypes tested across 14 environments. 
                                                 
 PC 1 denotes Principal Component 1 and PC 2 denotes Principal Component 2. 
Genotypes are in blue, growing environments are numbered 1 to 14, in red. 
1 = BR-Irr-06 
2 = BR-Dry-06 
3 = BI-Irr-06 
4 = BI-Dry-06 
5 = LB1-Irr-06 
6 = LB1-Dry-06 
7 = BR-Irr-07 
8 = BR-Dry-07 
9 = BI-Irr-07 
10 = BI-Dry-07 
11 = LB1-Irr-07 
12 = LB1-Dry-07 
13 = LB2-Irr-07 
14 = LB2-Dry-07 
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Figure 4.17 A scatter plot of 4-hydroxyisoleucine content (%) and growing environments (numbered 1 to 14) to illustrate the 
presence of genotype x environment interaction effect for 10 fenugreek genotypes tested across 14 environments in southern 
Alberta.
                                                 
 Environment 1 = BR-Irr-06; 2 = BR-Dry-06; 3 = BI-Irr-06; 4 = BI-Dry-06; 5 = LB1-Irr-06; 6 = LB1-Dry-06; 7 = BR-Irr-07; 8 = BR-Dry-07; 9 = BI-Irr-07; 10 
= BI-Dry-07; 11 = LB1-Irr-07; 12 = LB1-Dry-07; 13 = LB2-Irr-07; 14 = LB2-Dry-07.  
Note:  Environments are discrete variables, lines drawn connecting the data points are intended to exhibit the crossover interactions. 
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Hierarchical cluster analysis performed on 4-OH-ILE identified that Quatro MP 
30, Tristar, F96, F86 and L3312 have formed one cluster, while X92 and AC Amber have 
formed another cluster. F17 and Ind Temp were too different in their response patterns to 
be placed in the same cluster; hence each formed a cluster by itself (Fig. 4.18).  
The GGE biplot analysis performed for genotypes and environments on 4-OH-
ILE identifies Tristar, Quatro MP 30, X92 and Ind Temp as the most responsive 
genotypes, given their positions at the vertices of the polygon (Fig. 4.19). Tristar was the 
promising genotype in all environments positioned within its sector; this includes 5 (LB1-
Irr-06), 2 (BR-Dry-06), 11 (LB1-Irr-07), 7 (BR-Irr-07) and 8 (BR-Dry-07).Similarly, Ind 
Temp was the winning genotype in all environments located within its sector, which 
includes14 (LB2-Dry-07), 12 (LB1-Dry-07) and 13 (LB2-Irr-07), while Quatro MP 30 
was identified as the winning genotype at 9 (BI-Irr-07), the only environment located 
within its sector. Because it is located at the largest distance from the biplot origin, Ind 
Temp was considered the most responsive, but was also the most unstable genotype, 
indicated by its high PC 2 score. In contrast, the F75 genotype with a comparable mean 
4-OH-ILE to Ind Temp and Tristar had a relatively lower PC 2 score, indicating better 
stability (Fig 4.19). 
 
 
4.1.2.8 4-Hydroxyisoleucine productivity 
 
Following the trend of the other productivity traits, the main effect of 
environment on 4-hydroxyisoleucine productivity (4-OH-ILE-P) accounted for 71 % of 
the total variation due to treatments, whereas only 12 % of the total variation was  
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Figure 4.18 Dendogram depicting the hierarchical clustering of 10 fenugreek 
genotypes tested in 14 environments based on their 4-hydroxyisoleucine content 
(%). 
                                                 
 Similarity of clusters is based on Pearson correlation coefficients; agglomeration of the 
clusters based on unweighted pair-group average. Similar color groups represent a 
distinct cluster. The dotted line represents the truncation point for clusters. 
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Figure 4.19 The "which won where" view of the GGE biplot for mean 4-
hydroxyisoleucine content (%) of 10 fenugreek genotypes tested across 14 
environments. 
                                                 
 PC 1 denotes Principal Component 1 and PC 2 denotes Principal Component 2. 
Genotypes are in blue, growing environments are numbered 1 to 14, in red. 
1 = BR-Irr-06 
2 = BR-Dry-06 
3 = BI-Irr-06 
4 = BI-Dry-06 
5 = LB1-Irr-06 
6 = LB1-Dry-06 
7 = BR-Irr-07 
8 = BR-Dry-07 
9 = BI-Irr-07 
10 = BI-Dry-07 
11 = LB1-Irr-07 
12 = LB1-Dry-07 
13 = LB2-Irr-07 
14 = LB2-Dry-07 
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contributed by genotype main effect (Table 4.2). The remaining 17 % of the variability 
was attributed to the G x E interaction effect. For numerical values representing the G x E 
interaction for 4-OH-ILE-P, see Appendix II.  
The GGE biplot analysis for 4-OH-ILE-P on genotypes and environments 
identified Tristar, X92, Ind Temp, F86, L3312 and F75 as the most responsive genotypes, 
given their positions at the vertices of the polygon (Fig. 4.20). In terms of 4-OH-ILE-P, 
all environments except 1 (BR-Irr-06), 2 (BR-Dry-06), 3 (BI-Irr-06) and 9 (BI-Irr-07) 
were not discriminative of the genotypes tested as indicated by their close proximity to 
the biplot origin. F75 was the superior genotype for 4-OH-ILE-P in terms of 4-OH-ILE-P 
as well as stability, given its high PC 1 and low PC 2 (close to zero) scores.  
 
 
 
4.2 Trait profiles of genotypes and the association of traits   
evaluated in the study 
 
Pearson correlation coefficient values (r-values) representing associations among 
the selected eight traits examined are given in Table 4.4. Results indicate a strong 
negative correlation between TSW and SY (r = -0.712). On average, the DIOS in the 
seeds was shown to respond positively with TSW (r = 0.749), and negatively with GLM 
(r = -0.698). The productivity of the three biochemical traits, GLM-P, DIOS-P and 4-OH-
ILE-P was positively and highly correlated to SY as indicated by their r-values; i.e., 
0.989, 0.700 and 0.960, respectively.  
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Figure 4.20 The "which won where" view of the GGE biplot for mean 4-
hydroxyisoleucine productivity (kg ha-1) of 10 fenugreek genotypes ested across 14 
environments. 
                                                 
 PC 1 denotes Principal Component 1 and PC 2 denotes Principal Component 2. 
Genotypes are in blue, growing environments are numbered 1 to 14, in red. 
  
1 = BR-Irr-06 
2 = BR-Dry-06 
3 = BI-Irr-06 
4 = BI-Dry-06 
5 = LB1-Irr-06 
6 = LB1-Dry-06 
7 = BR-Irr-07 
8 = BR-Dry-07 
9 = BI-Irr-07 
10 = BI-Dry-07 
11 = LB1-Irr-07 
12 = LB1-Dry-07 
13 = LB2-Irr-07 
14 = LB2-Dry-07 
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This association can also be observed visually in a biplot analysis; i.e. positive or 
negative associations can be visualized by looking at the angles between trait vectors. 
DIOS-P was positively correlated with the amount of diosgenin found in seeds (acute 
angle,  < 90º) and negatively correlated with TSW (obtuse angle,  > 90º) (Fig. 4.21). 
TSW and GLM were significantly and negatively correlated to each other (straight angle, 
  180º). The angles between trait vectors for SY, GLM content and 4-OH-ILE-P were 
smaller than 90º, indicating a strong positive correlation among these traits (Figure 4.21). 
The associations among trait profiles (strengths and weaknesses) of genotypes are also 
indicated (Fig. 4.21). A close association between trait and genotype vectors was 
observed for genotype AC Amber and DIOS indicating that AC Amber was the best 
performing genotype for producing the steroid diosgenin. However, Quatro MP 30 was 
the best yielding genotype in terms of DIOS-P. On average, fenugreek genotype F75 was 
the best genotype in terms of SY, 4-OH-ILE-P and GLM-P.  Tristar appeared to be the 
best genotype in terms of 4-OH-ILE. None of the genotypes tested was clearly indicated 
as being superior in terms of GLM (Fig. 4.21).
 110 
 
 
Table 4.4 Correlation coefficient (r) values among means of 8 traits assessed in 10 fenugreek genotypes grown across 14 
environments. 
 
TSW SY GLM GLM-P DIOS DIOS-P 4-OH-ILE 
SY -0.712       
GLM -0.850 0.658      
GLM-P -0.760 0.989 0.753     
DIOS 0.749 -0.563 -0.698 -0.619    
DIOS-P -0.230 0.700 0.186 0.640 0.190   
4-OH-ILE -0.092 0.009 0.039 0.014 -0.128 -0.064  
4-OH-ILE-P -0.740 0.960 0.709 0.964 -0.574 0.647 0.252 
§ TSW, thousand seed weight; SY, seed yield; GLM, galactomannan content; GLM-galactomannan productivity; DIOS, diosgenin 
content; DIOS-P, diosgenin productivity; 4-OH-ILE, 4-hydroxyisoleucine content; 4-OH-ILE-P, 4-hydroxyisoleucine productivity. 
Values in bold are significantly different from zero (p ≤ 0.05).
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Figure 4.21 Genotype x trait biplot for 10 fenugreek genotypes tested across 
14 growing environments.  
                                                 
Traits parameters are in uppercase and genotypes are in lower case. PC 1 and PC 2 are 
primary and secondary effects, respectively. TSW = 1000-seed weight; SY = seed yield; 
GLM = galactomannan content; GLM-P = galactomannan productivity; DIOS = 
diosgenin content; DIOS-P = diosgenin productivity; 4-OH-ILE = 4-hydroxyisoleucine; 
4-OH-ILE-P = 4-hydroxyisoleucine productivity. 
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5.0  Discussion 
 
5.1 Thousand seed weight 
Thousand seed weight (TSW), generally referred to as the average seed weight is 
an essential yield component trait in crop studies as it can assist producers in accounting 
for seed size variation (Ellis, 1991). The average seed weight in turn becomes useful to 
determine seeding rates and combine losses, and in some cases can help indicate seed 
quality (i.e., plumpness or shrinkage) resulting from various treatments. Seed size and 
TSW can vary among species of the same crop plant, from year to year, as well as among 
growing environments. A simple scatter plot of TSW against growing environments 
provides a visual representation of the crossover interaction effect of genotype response 
(change in genotype rankings) when tested across varying environments. A larger seed 
weight is usually associated with larger seed and may extend benefits in terms of better 
seed survival, faster seedling growth and higher reproduction rates (Halpern, 2004).  It 
was recently shown that concentrations of biochemical components such as isoflavones 
and phenolic compounds in large, medium and small-sized soybean seeds not only 
correlated with seed size but were also occasionally influenced by seed size x site 
interactions (Lee et al., 2008). For this study, TSW and the production of galactomannan, 
diosgenin and 4-hydroxyisoleucine were expected to be correlated, as larger seeds 
generally carry out metabolism at greater rates, hence inherently become more equipped 
biochemically (Ellis, 1991; Grieve and Francois, 1992; Kidson and Westoby, 2000). 
Significant correlation coefficient values negatively associating TSW with 
galactomannan and positively with diosgenin provided strong evidence that a relationship 
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between seed size and these biochemical characteristics do exist. This suggests that levels 
of galactomannan tend to be lower in larger seeds while levels of diosgenin increase with 
increasing seed weight (or size). Galactomannan content may be lower in larger seeds 
due to a larger surface area to volume ratio as this structural compound is generally found 
deposited around the seed coat. On the contrary, diosgenin is mainly concentrated around 
the seed embryonic section, thus a larger seed with a larger embryo is expected to have 
greater diosgenin content. The dendogram (Fig 4.1) shows the grouping of diosgenin 
content and TSW into one cluster indicating the relationship mentioned above; i.e. seeds 
with higher TSW (larger seeds), also had higher diosgenin content. However, this 
hypothesis needs to be further investigated. 
The biplot analysis (Yan et al., 2001) identifies genotype with high mean 
performance by large values of primary effects (PC 1) and stable genotypes by values 
close to zero for secondary effects (PC 2). In a similar way, the biplot analysis can also 
help discern the most discriminative growing environments among genotypes for high 
performance and stability. For TSW, AC Amber had the largest seed weight, represented 
by its high primary effects, but was relatively unstable compared to X92 and the low-
performance genotypes, F17 and Tristar (all of which displayed small secondary effects). 
The genotype Indian Temple, although ranked third in average weight, was the most 
unstable indicating inconsistent performance. Perpendicular rays from the origin divided 
the biplot into 5 sectors, with the majority of the growing environments located outside 
the polygon near AC Amber, indicating a possible mega environment. Also, rainfed-
growing environments (even numbered) predominantly occupied this sector, suggesting 
that high seed weight may correlate to low moisture conditions (stress environments). 
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5.2 Seed yield 
The fenugreek genotypes selected for this study were previously adapted for 
growth in arid regions of Western Canada, and were bred for high seed yields and/or 
biomass production as well as for early maturity over the last decade. In recent years, a 
modern genomics approach for crop improvement has been widely explored (Varshney et 
al., 2006, Vij and Tyagi, 2007; Tuberosa and Salvi, 2008) as these methods would allow 
for more precise crop modification over relatively shorter periods of time (Basu et al., 
2007). For fenugreek, Basu et al. (2008) adopted a mutation breeding approach using 
ethyl methane sulfonate to improve seed yield and plant growth habit of Tristar, one of 
the genotypes tested in the current study.  
Yield stability is one the major concerns for crop breeders in multi-environmental 
trials (Piepho, 1999) because genotype x environment interactions often can be an 
impediment to stable crop production (Yang, 2007). In this study, significant genotype x 
environment interaction on seed yield was indicated in the change in genotype rankings 
across growing environments (Fig 4.6). Seed yield was found to be the predominant 
factor in the productivity of galactomannan (r = 0.99), diosgenin (r = 0.70) and 4-
hydroxyisoleucine (r = 0.96). Hierarchical clustering of the dependent variables; seed 
yield and all three compound productivity data for genotypes, grouped these traits 
together within a single cluster, indicating their similar response patterns. The dendogram 
produced for seed yield using genotypic means grouped F75, Quatro MP 30, F96, L3312 
and Tristar into one cluster. Based on performance means and the GGE biplot analysis, 
these same genotypes also had the best seed yields. In the biplot, F75 was shown as the 
most promising genotype, with Bow Island Irrigated 2006 as its niche environment. 
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Among the highest yielding genotypes, F75, L3312 and F96 were the most stable, as 
exhibited by their high primary effects and close to zero secondary effects (Fig. 4.8). 
Despite their low yields, X92 and Indian Temple were also stable genotypes, suggesting 
that they are potential parental materials in view that they were high in diosgenin and 4-
hydroxyisoleucine contents, respectively. Bow Island-irrigated 2006 and Bow Island-
irrigated 2007 were the most valuable in differentiating among genotypes in terms of 
seed yield; while Brooks-irrigated 2006 and Brooks-rainfed 2006 were ineffective due to 
their high secondary (PC 2 scores) effects. Both Bow Island-irrigated 2006 and Bow 
Island-irrigated 2007 were sites with favorable soil moisture conditions and consequently 
produced the highest seed yields among the growing environments tested.                                                  
 
5.3 Galactomannan productivity 
Galactomannans represent a major group of polysaccharide fiber in fenugreek seeds 
found concentrated in the seed coat surrounding the endosperm (Meier and Reid, 1977). 
Genetic variability of fenugreek for galactomannan content can range from 17 - 50 % of 
dry seed weight (Petropoulos, 1973 cited in Petropoulos, 2002; Meier and Reid, 1977; 
Duke, 1986; Kocchar et al., 2006; Srichamroen et al., 2008). Levels of galactomannan in 
seed could also vary according to biogeographic origins; i.e. fenugreek of Indian origin 
had higher galactomannan content compared to that from Ethiopia, and fenugreek from 
the Mediterranean area was generally inferior producers of the bioactive compound 
(Petropoulos, 1973 cited in Petropoulos, 2002). In this study, F75 the genotype of Afghan 
origin performed significantly better in terms of seed yield compared to the genotypes 
from Iran (F17) and India (Indian Temple).  
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Unique, relative to other commonly used galactomannans such as those found in 
guar and locust beans, fenugreek galactomannan contains a galactose to mannose ratio of 
1:1 (Reid and Meier, 1970). The high degree of galactose substitution renders the 
molecule relatively hydrophilic (Brummer et al., 2003), making galactomannan a good 
emulsifier and stabilizer in oil-water mixtures as well as a good thickener for use in foods 
(Slinkard, 2002). Apart from its industrial potential, the soluble nature of galactomannan 
fiber from fenugreek has been shown to exert anti-diabetic (Sharma, 1986b; Madar et al., 
1988) and hypocholesterolemic effects (Sharma, 1986a; Venkatesan et al., 2003) by 
reducing plasma glucose levels (Madar and Shomer, 1990) and inhibiting bile salt 
absorption in the gut (Dakam et al., 2007). 
In the present study larger seeds were shown to accumulate lower amounts of 
galactomannan (r = - 0.85), and vice versa. Genotypes with lower average seed weight 
(smaller seeds) such as F75, Quatro MP 30 and L3312 had both high seed yields and 
galactomannan contents. The positions of these genotypes at polygon vertices in the 
biplot analysis (Fig. 4.12) also indicate their high responsiveness to environment niches. 
Among the best yielding genotypes, L3312 was identified as being the most stable. 
Genotypes F75, Quatro MP 30 and L3312 had the highest galactomannan productivity, 
and were shown to be both the best performing and most stable genotypes for this trait 
while Brooks-rainfed 2006 was the most discriminating environment. Interestingly, a 
significant negative correlation between diosgenin and galactomannan contents  
(r = -0.698) was observed; this is also shown in the “genotype by trait” biplot (Fig 4.21) 
where DIOS and GLM are separated by an obtuse angle (α > 90°). This suggests that 
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there is a trade-off relationship between these two compounds in the seed, since there was 
no one genotype that prevailed for both traits.  
Environmental effects (E) accounted for 70 – 74 % of the total variation for 
galactomannan content (%) and its productivity (kg ha-1), while genotype (G) and G x E 
interaction effects accounted for only 10 - 11 % and 15 – 19 %, respectively. This 
indicates that environments have a greater influence on the production of these traits in 
fenugreek, and suggests that non-genetic factors are involved in crop performance (Yang 
and Baker, 1991; Gallacher, 1997). Under some circumstances, it may be more cost and 
time effective to propose improving agronomic systems rather than attempting genetic 
manipulations for the purpose of increasing crop performance for this trait (R.C. Yang, 
personal communication, 2008). However, since a significant positive correlation was 
observed between galactomannan productivity and both seed yield and galactomannan 
content, it is clear that productivity of this compound is reliant on the synergism of these 
traits.  Therefore, it is imperative to use an extremely stable, high seed-yielding genotype 
such as F75 and another such as F17 that contains fairly high levels of galactomannan to 
as parents to develop fenugreek lines has both yield performance and stability.   
                                                 
 R.C. Yang is an Adjunct Professor of Statistical Genomics and Quantitative Genetics 
with the Department of Agricultural, Food and Nutritional Science at the University of 
Alberta (Edmonton, Alberta, Canada). 
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5.4  Diosgenin productivity 
Steroidal sapogenins such as diosgenin are extensively used as raw materials by 
both the pharmaceutical and nutraceutical industries for the manufacture of steroidal 
drugs and medicinal extracts (Raghuram et al., 1994; Skaltsa, 2002). Traditionally 
diosgenin has been extracted from wild Mexican and Asian yam species. However, with 
increasing demand for raw steroids, fenugreek seeds have been proposed as a viable 
alternative source of diosgenin due to the plant’s shorter growing cycle, lower production 
costs and consistent quality (Fazli and Hardman, 1968 cited by Petropoulos, 2002). 
Significant variability in biochemical and physical attributes among fenugreek genotypes 
due to genotype x environment (G x E) interactions has been identified (Acharya et al., 
2006). Depending upon biogeographic origins, genotypes and environmental factors, 
reported diosgenin contents in fenugreek vary between 0.3 and 2.0 % (Fazli and Hardman, 
1968; Puri et al., 1976; Sharma and Kamal, 1982; Taylor et al., 2002).  Taylor et al. 
(2002) specifically evaluated the diosgenin contents of selected fenugreek genotypes 
grown in western Canada and found G x E interaction effects to be significant in 
explaining the variation observed. In the current study, AC Amber and X92 were 
identified as the best performing genotypes in terms of diosgenin content which is 
consistent with the findings reported by Taylor et al. (2002), where these two genotypes 
were found to contain the highest levels of diosgenin in seeds among the selected 
fenugreek genotypes that were grown in western Canada.                                                                             
Genotypes used for this fenugreek study were previously selected based primarily 
on high seed and/or biomass production as well as early maturity. From this study, high 
diosgenin-producing genotypes such as AC Amber and X92 were identified, which can 
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be used to provide potential parental materials for future genotype development. A 
significant and positive association was observed between diosgenin content and average 
seed weight (r = 0.75), while a negative correlation was observed between levels of 
diosgenin and galactomannan (r = -0.70). This suggests that diosgenin levels in seeds 
tend to increase with increasing seed weight (or size) due to the presence of a larger 
embryonic area, where the complex precursors (furastanol glycosides) of sapogenins are 
concentrated in the seed (Skaltsa, 2002). 
Hierarchical clustering of genotypes may provide a good indication of how similar 
the genotypes responded to varying growing conditions when tested across different 
environments. In terms of diosgenin content, the cluster analysis grouped F86 and Tristar 
in one cluster, and Indian Temple, X92, AC Amber and L3312 into another cluster. F96, 
F75, Quatro MP 30 and F17 were too different from each other to be grouped together 
into a single cluster. Such groupings, although not applicable at this point of the study, 
allow for better predictions of the performance of similarly clustered genotypes in future 
trials. The GGE biplot analysis clearly showed the superiority of AC Amber and X92 as 
the best performing genotypes, dominating at all environments except for Lethbridge 
(Fed)-rainfed 2007. X92 also demonstrated high stability, as indicated by its low absolute 
secondary (PC 2) effects. The potential for fenugreek to be used as a source of diosgenin 
is ultimately dependent on productivity of the compound; this study indicates that 
diosgenin productivity is directly related to seed yield. This observation is supported by 
the biplot analysis for diosgenin productivity where the high seed-yielding genotypes F75 
and Quatro MP 30 occupied the far right vertices of the polygon, winning at Brooks-
irrigated 2006 (1) and Bow Island-rain fed 2006 (3), and Brooks-rain fed 2006 (2) and 
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Bow Island-irrigated 2007 (9), respectively. Other tested environments were located near 
the biplot origin, and hence were less discriminative for genotypic contributions (Yan et 
al., 2001).  
Environmental effects accounted for only 6% of the total variation in diosgenin 
productivity. This strongly suggests the presence of significant genetic control for 
diosgenin production in fenugreek seeds and that perhaps one or a few major genes may 
influence this trait (R.C. Yang, personal communication, 2008). In this case, there is 
greater justification for genetic manipulation of genotypes for diosgenin productivity, 
which may be more effective when combined with agronomic improvements. In this 
study, a stable but low seed yielding genotype such X92, which contains high levels of 
diosgenin, and high seed yielding genotypes such as F75 and Quatro MP 30 may be 
excellent parental material for the development of superior genotypes with high 
diosgenin content and productivity. 
 
5.5 4-Hydroxyisoleucine productivity 
4-Hydroxyisoleucine is the most abundant free amino acid in fenugreek seeds 
(Sauvaire et al. 1984; Gupta et al., 1998,). Evidence suggests that 4-hydroxyisoleucine 
has anti-diabetic (Petit et al., 1995a; Sauvaire et al., 1996; Broca et al., 1999) and anti-
obesity properties in animal studies (Handa et al., 2005; Narender et al., 2006). These 
findings are generating considerable interest in fenugreek by pharmaceutical and 
nutraceutical industries (Basch et al., 2003, Acharya et al., 2008;). Levels of fenugreek 4-
hydroxyisoleucine content was also shown to vary according to the biogeographic origins 
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of the crop; i.e.  Hajimehdipoor et al., (2008) reported a 4-hydroxyisoleucine content of 
0.4% in Iranian fenugreek seeds, while Narender et al. (2006) reported a  
4-hydroxyisoleucine content of just 0.015 % in Indian fenugreek seeds. In this study,  
4-hydroxyisoleucine contents among genotypes tested across different growing 
environments averaged ~ 1 %.  
 Although 4-hydroxyisoleucine is present in the seed endosperm (Al-Habori and 
Raman, 2002; Skaltsa, 2002), no relationship was found between its level in seed and the 
other trait parameters measured, except for 4-hydroxyisoelucine productivity (r = 0.65). 
Mean 4-hydroxyisoleucine content among genotypes (RSD = 5.9 %) did not vary as 
much as that observed among environments (RSD = 18.9 %), indicating that environment 
contributed more to the variability observed. Tristar, F75 and Ind Temp were identified 
as the best performing genotypes in terms of 4-hydroxyisoleucine. Hierarchical clustering 
of genotypes based on 4-hydroxyisoleucine contents grouped Tristar, F75, Quatro MP 30, 
F96, F86 and L3312 together under one cluster, while AC Amber and X92 were grouped 
into another cluster. These groupings represent a good indication of how similar the 
genotypes responded (in terms of 4-hydroxyisoleucine content) to the varying growing 
conditions when tested across different environments. Consequently, genotypes Quatro 
MP 30, F96, F86 and L3312, which reported significantly lower means than Tristar and 
F75, are a poor choice for breeding material to increase 4-hydroxyisoleucine contents in 
fenugreek. Results from the hierarchical cluster analysis determined that Ind Temp too 
different in its response pattern to be clustered with other any of the other genotypes 
hence formed a cluster by itself.  This was also observed in the biplot analysis for 4-
hydroxyisoleucine content (Fig 4.19) where Ind Temp was shown to have the highest 
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primary effects (best yield) but also the highest secondary effects, indicating significant 
instability. Among the high performing genotypes, F75 with its close to zero secondary 
effects was determined to be the most stable. As with the other bioactive compounds 
evaluated, the potential of fenugreek as a source of 4-hydroxyisoleucine relies on the 
productivity of this compound. Seed yield and 4-hydroxyisoleucine productivity were 
strongly positively correlated (r = 0.96), indicating that seed yield contributed 
significantly to productivity of this compound. The genotype Ind Temp, despite being 
very stable in terms of 4-hydroxyisoleucine productivity (low secondary effects), had low 
primary (PC 1) effects indicating low yield (Fig. 4.20).  Consequently, this genotype is 
considered unsuitable for farm-scale commercialization.  The complementary trait 
profiles of Ind Temp and F75 suggest that these genotypes are potential parental 
materials for increasing 4-hydroxyisoleucine contents in fenugreek cultivar development.  
 
5.6 Crop productivity potential 
The genotypes chosen for this study were previously adapted for growth in semi-
arid regions of western Canada, and were selected for high seed and/or forage yield as 
well as for early maturity. This trait profile is essential as the number of frost-free days in 
this region average only about 100 days (Acharya et al., 2006). Therefore, these 
genotypes already represent an elite germplasm prior to the commencement of the study.  
To ensure a genetically diversified collection of starting materials, the genotypes were 
selected based on their various geographic origins. The generation of varying growing 
environments, manipulated by the combination of year x location x growing conditions 
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was crucial in providing a multi-environment platform for the selection of high 
performing genotypes with high stability.  
This study aims to identify potential fenugreek genotypes with high levels of 
galactomannan, diosgenin and 4-hydroxyisoleucine productivity with stable yield.  
However, due to genetic variation and interaction with growing environments, it was not 
possible to identify any one genotype that prevailed for all traits. The GGE biplot 
presenting “which won what” for the 8 traits assessed in 10 fenugreek genotypes provides 
a visual display of the relationship of genotypes with each of the traits, as well as the 
relationship between traits (Fig. 4.21).  Fenugreek genotypes AC Amber, Quatro MP 30, 
F75, F17 and Ind Temp were identified as the most responsive genotypes for all traits due 
to their locations at the vertices of the polygon. While AC Amber was the best genotype 
in terms of diosgenin content, Quatro MP 30 was superior in terms of diosgenin 
productivity. The most stable genotypes for 4-hydroxyisoleucine content were F17 and 
Tristar but productivity overall for 4-hydroxyisoleucine and galactomannan as well as 
seed yield was best in F75.  
From this two-year study conducted on ten selected fenugreek genotypes tested 
across fourteen growing environments, several promising genotypes were identified as 
parental material for future breeding and selection efforts. As this fenugreek study 
focuses on selecting potential genotypes for the functional food and nutraceutical 
industry, genotypes which demonstrated high productivity of galactomannan (F75, 
Quatro MP 30 and L3312), diosgenin (Quatro MP 30 and F75) and 4-hydroxyisoleucine 
(F75) are the most useful for future crop improvement efforts. The genotype, F75 is of 
Afghan origin and demonstrated superior stability and high performance for all yield-
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related traits. Genotypes such as Tristar and L3312 were originally selected as lines for 
forage purposes meant for the animal feed industry. However, this study managed to 
identify new functionalities for these genotypes, extending their trait profiles. The zero-
tannin X92 genotype is a unique experimental line that has a cream-colored seed coat. 
This phenotype may be desirable in large-scale processing to create a light-colored 
product, which may have a greater consumer appeal. Also, despite its low seed yield, X92 
reported excellent stability and performance for diosgenin content. Low yield 
performance is often associated with stability (static stability) as demonstrated by X92; 
due the lack of space for fluctuations (Lin et al., 1986). It would be worthwhile to explore 
the genetic basis for such stability as well as the underpinning chemistry for the trade-off 
between tannin and diosgenin. Despite demonstrating environmental instability, Ind 
Temp reported one of the highest mean 4-hydroxyisoleucine contents (1.46 %), and was 
on average among the best performing genotypes for this trait. Therefore, this genotype 
may provide suitable genetic material for the development of superior fenugreek lines 
with high 4-hydroxyisoleucine productivity. 
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6.0 Future prospects 
 
 
Fenugreek has been commercially grown in western Canada for only 16 years, 
dating back to 1992 with the release of the first cultivar “AC Amber” by Agriculture and 
Agri-Food Canada (AAFC) in Morden, Manitoba. Although the fenugreek crop has 
traditionally been grown for seed to supply the spice industry, fenugreek cultivars have 
been developed and released in western Canada since the release of  “AC Amber” for 
specific purposes; i.e. CDC Canafen used mainly for galactomannan extraction, and CDC 
Canagreen and Tristar grown mainly for forage use. However, primary selection criteria 
of these newly developed cultivars were based on high seed and/or forage yield as well as 
for early maturity.  
With accumulation of more experimental evidence in support of the nutraceutical 
properties of fenugreek, there is growing interest in marketing fenugreek as a natural 
health product in Canada. Therefore, there is a need to evaluate the biochemical 
productivity of fenugreek to allow for selection of suitable genotypes that may be further 
developed into cultivars specific for the natural health product industry. In this study, the 
productivity of three bioactive compounds (galactomannan, diosgenin and 4-
hydroxyisoleucine) was assessed by testing 10 fenugreek genotypes across 14 growing 
environments (year x location x growing condition). 
Yield stability for crops is usually hampered by genotype x environment 
interaction effects, causing genotypes to respond differently when grown at different 
locations and even in different years. In view of this counter-productive phenomenon and 
the increasing need for more cost-effective cultivar testing, crop improvement programs 
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require a multi-environmental design with greater focus on identifying yield-stable 
genotypes with satisfactory performance across homogenous growing environments. 
In this study, genotype, environment and their interaction effects were significant 
for all trait parameters evaluated. Environmental effects accounted for more than 60 % of 
the total variation observed for each trait, with the exception for diosgenin content. The 
high variance proportion explained by environmental effects indicates a greater influence 
of environmental factors on the productivity of these traits. In this case, under some 
circumstances, it may be more cost and time-effective to improve trait performances in 
genotypes by embracing an agronomic approach (enhancing field-related systems; i.e. 
available moisture, crop row-spacing, fertilizer application). However, in situations 
where genetic factors are dominant, such as the case observed for diosgenin content 
(environmental effects accounted for only 6 % of the total variance), it may be 
worthwhile exploring a molecular genetics approach (identification of contributing 
genes) combined with agronomic improvements to increase crop performance.  
Productivity of the bioactive compounds was evaluated based not only on high 
mean performance but also productivity stability (Table 6.1). Genotypes that 
demonstrated the least genotype x environment interaction were the most stable and are 
desirable in crop improvement programs; i.e. F75 that had high seed yield, 
galactomannan content and productivity. However, genotypes that were high performing 
on average, but were unstable across environments could be equally useful as sources of 
unique genes for future crossbreeding efforts; i.e. Ind Temp which had a high 4-
hydroxyisoleucine content. Likewise, genotypes that have high stability and high 
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performance, but low productivity due to low seed yield may also serve as good parental 
material for future cultivar development; i.e. X92 which had a high diosgenin content. 
Homogenous growing environments that have similar biotic and abiotic stresses 
can be termed, “mega environments” when they produce similar genotype rankings. 
These are also useful for selecting and/or discriminating among responsive genotypes. 
Mega environment studies would be useful in the long run to identify similarly 
contributing environments. This would allow us to recommend cultivars according to 
their environmental profiles, and from a more academic perspective, to avoid duplicating 
test locations for future breeding studies. This fenugreek study is based on a two-year 
data set and hence, is not adequate for decisive identification of mega environments (may 
require at least three years to identify); genotype rankings must be repeatable on average 
for three consecutive years (Yan and Kang, 2003).  
There is growing interest in the medicinal properties of fenugreek due to 
contributing science-based evidence implicating some of the principal biochemical 
components likely responsible for its health effects. However, most clinical researchers 
studying the effects of fenugreek do not consider the genetic and environmental response 
variability of the crop. Biotic and abiotic stresses may exert pressure on growing plants 
and cause variation in their chemical and physical properties. Occasionally, contradicting 
drug efficacy results from different clinical studies using allegedly similar testing 
material may be attributed to these variations.  Attention given to this aspect would lead 
to better agreeability and could lead to dosage standardization among clinical trials. 
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Table 6.1 Clusters of fenugreek genotypes based on the magnitude and stability of agronomic and biochemical traits 
evaluated in this study. 
Agronomical/ biochemical trait Magnitude of performance Stability of performance 
Thousand seed weight 
AC Amber X92-23-32T 
Seed yield 
F75, Quatro MP 30, L3312, F96 F75, F96, L3312 
Galactomannan content 
F75, F17, Quatro MP 30, L3312 Tristar, F17, F96 
Galactomannan productivity 
F75, Quatro MP 30  
Tristar, Quatro MP 30, F96, 
L3312, F75 
Diosgenin content 
AC Amber, X92-23-32T X92-23-32T 
Diosgenin productivity 
Quatro MP 30  
X92-23-32T, F96, Indian Temple, 
F17 
4-Hydroxyisoleucine content 
Indian Temple, Tristar, F75, 
AC Amber 
F96 
4-Hydroxyisoleucine productivity 
F75, Quatro MP 30, Tristar 
Indian Temple, F96, AC Amber, 
F75 
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 Through this study, we now have a better understanding of the trait profiles of 
these ten genotypes that were previously selected in southern Alberta mostly on the basis 
of high seed yield and early maturity traits. The multi-environment design in this study in 
which fenugreek genotypes were tested across 14 different growing environments was 
essential in evaluating their stability in yield performance. Assessment of the genotype 
(G) and environment (E) main effects as well as the G x E interaction effects provided 
valuable information on the relative contribution of these effects on the traits evaluated in 
this study. In terms of diosgenin content, it is unusual in crop trials that environmental 
effects contributed only 6 % towards the total variation observed for this trait. This will 
provide a strong basis for future studies of the genetic basis of diosgenin production in 
fenugreek. Determination of the bioactive compound content in the ten fenugreek 
genotypes enabled selection of those that were productive in one or more of the 
biochemical components studied. Stable genotypes, i.e. those with the least genotype x 
environment interaction, were also identified and can be further selected with high 
yielding genotypes for future crop improvement studies. The preliminary identification of 
the potential genotypes (Table 6.1) in this study represents a vital progressive step 
towards the selection and subsequent recommendation of fenugreek cultivars as a source 
of natural health products to producers and processors in Alberta. 
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Appendix I 
 
 
Mean maximum and minimum temperatures at the test sites from May to September in 2006 and 2007. 
 Mean maximum/ minimum temperatures (ºC) 
Test sites May June July August September 
2006 Brooks 20.0 / 5.7 24.0/ 10.2 29.8/ 12.1 27.1/ 8.9 22.8/ 5.0 
2006 Bow Island 20.5 / 6.4 23.6/ 10.8 29.5/ 12.8 27.4/ 9.7 21.1/ 5.7 
2006 Lethbridge 30.9/ -4.6 30.9/ 5.4 32.4/ 7.5 33.1/ 3.9 30.0/ -3.2 
2007 Brooks 19.4 / 4.6 24.0/ 8.6 31.1/ 13.2 25.4/ 9.1 19.3/ 3.9 
2007 Bow Island 19.2/ 5.7 23.9/ 9.8 31.3/ 14.2 26.7/ 10.1 19.6/ 4.3 
2007 Lethbridge 26.7/ 0.3 27.8/ 5.1 34.4/ 6.4 32.7/ 2.3 28.9/ -2.1 
               Source: Irrigation Management Climate Information Network (IMCIN), 2008. 
 146 
 
Appendix II 
 
 
 
Numerical Values for Productivity of the Ten Fenugreek Genotypes Grown in Different 
Environments across Southern Alberta 
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Mean thousand seed weight (g) of ten fenugreek genotypes grown at fourteen environments in southern Alberta. 
 Environment 
Genotype 
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Thousand seed weight (g) 
Tristar 14.3 16.8 15.0 11.9 13.9 16.5 11.9 12.3 16.0 11.5 17.6 11.3 12.0 10.2
Quatro 
MP 30  14.1 15.7 14.3 10.9 14.1 15.6 10.3 12.3 18.1 9.7 17.3 10.2 12.1 9.2
AC 
Amber 15.6 22.0 14.0 17.3 16.5 21.6 14.6 15.6 19.6 15.8 23.6 16.6 17.8 15.1
F17 12.2 15.7 13.1 12.4 13.1 16.1 10.7 12.3 16.0 11.5 16.4 10.7 12.0 9.6
F96 15.2 17.9 16.3 12.5 15.1 17.6 11.8 13.2 19.0 12.7 20.9 12.7 14.0 12.0
F75 14.9 15.3 14.3 11.1 12.1 15.4 10.9 12.2 16.8 9.7 16.5 9.7 11.5 9.5
X92 14.2 19.4 13.4 17.4 15.2 19.2 12.4 12.1 18.7 16.2 19.1 13.4 16.8 12.5
Ind Temp 17.8 18.8 15.9 14.7 14.5 17.5 14.1 14.4 17.0 12.2 15.8 13.6 15.5 12.7
L3312 14.1 17.2 18.7 14.1 15.5 17.4 11.5 12.7 17.8 11.8 18.9 12.2 12.3 11.2
F86 15.1 15.7 15.3 12.6 14.6 17.3 10.3 11.8 17.1 11.9 18.4 11.5 11.7 12.1
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Mean seed yield (kg ha-1) of ten fenugreek genotypes grown at fourteen environments in southern Alberta. 
 Environment 
Genotype 
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 Seed yield (kg ha
-1) 
Tristar 2618 3584 2629 1448 681 1319 1264 378 3037 1492 1093 698 1163 802 
Quatro 
MP 30  2839 3634 3286 1658 918 1806 1382 434 2856 1329 1256 698 1359 808 
AC 
Amber 1696 2575 1620 1705 848 1110 1089 343 1906 1443 391 468 840 735 
F17 2693 4040 1905 1670 979 1475 1397 248 2079 1511 969 729 1214 662 
F96 3264 3511 2637 1806 883 1693 1053 419 2533 1572 773 618 1203 671 
F75 3443 3852 3847 1813 994 1969 1288 314 2766 1481 944 613 1394 678 
X92 1912 1958 527 1377 364 1119 838 426 1253 955 802 545 1146 703 
Ind 
Temp 1645 1569 1006 1180 734 756 962 175 1801 1093 746 328 871 558 
L3312 3146 3619 3210 1788 543 1713 1248 351 1892 1570 989 703 1140 776 
F86 3965 2677 3404 1540 780 1424 1050 562 1968 1454 768 642 1100 323 
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Mean galactomannan content (%) of ten fenugreek genotypes grown at fourteen environments in southern Alberta. 
 
 
 Environment 
Genotype 
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Galactomannan content (%) 
Tristar 20.6 17.9 19.3 22.5 15.3 17.3 12.9 13.1 16.2 16.9 15.5 14.3 15.6 15.3
Quatro 
MP 30  19.3 19.0 19.1 21.2 15.7 15.4 12.4 12.0 16.9 17.1 17.4 16.7 13.7 15.6
AC 
Amber 17.3 18.1 12.2 19.8 13.4 16.2 10.8 11.0 16.1 16.1 14.6 12.7 13.3 13.2
F17 15.6 19.8 20.0 23.2 17.7 17.9 14.0 11.9 17.0 17.1 16.6 15.2 14.9 15.0
F96 17.4 15.6 16.8 22.3 16.0 17.9 12.9 11.3 16.0 16.1 16.0 13.4 13.9 13.1
F75 16.4 19.1 17.6 23.5 16.6 20.0 15.7 14.3 15.7 19.9 16.6 17.0 16.6 17.4
X92 17.8 16.5 16.0 21.4 16.4 15.4 14.6 13.1 15.6 16.9 16.8 15.1 13.8 16.0
Ind 
Temp 15.6 16.9 17.7 21.0 15.3 15.8 13.6 13.9 14.6 14.5 15.8 16.9 11.8 14.0
L3312 17.2 21.5 20.7 21.3 15.9 16.9 15.3 13.7 16.6 17.5 16.3 16.0 15.5 15.3
F86 17.1 18.0 19.7 19.2 12.8 17.2 13.3 13.9 16.3 17.3 16.4 16.2 15.7 14.8
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Mean galactomannan productivity (kg ha-1) of ten fenugreek genotypes grown at fourteen environments in southern Alberta. 
 Environments 
Genotype 
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Galactomannan productivity (kg ha-1) 
Tristar 540.2 642.8 506.3 325.9 104.5 227.8 163.6 49.5 491.5 252.3 168.9 100.0 181.5 122.8
Quatro 
MP 30  548.3 689.5 628.6 351.1 144.3 277.7 171.4 52.1 484.0 226.7 218.2 116.4 186.5 125.8
AC 
Amber 293.5 465.8 197.3 337.5 113.3 179.6 117.4 37.8 306.6 231.6 57.0 59.6 111.8 96.8
F17 420.0 799.6 381.9 387.1 173.6 264.4 195.0 29.6 352.4 258.1 161.1 110.8 180.7 99.2
F96 567.5 549.3 442.3 403.3 141.6 303.4 136.1 47.4 406.1 253.1 123.6 83.0 167.2 87.8
F75 565.8 736.6 676.3 425.3 164.4 393.8 201.6 45.0 433.7 294.6 157.0 104.1 231.3 117.6
X92 341.0 322.2 84.6 294.8 59.8 172.1 122.7 56.0 194.9 161.5 134.5 82.5 158.0 112.3
Ind 
Temp 255.9 265.3 178.3 247.3 112.5 119.5 130.7 24.3 263.6 158.8 117.7 55.3 102.7 78.2
L3312 542.0 779.3 663.0 380.7 86.5 290.2 190.7 48.1 314.9 274.0 161.5 112.6 177.2 118.7
F86 678.4 481.3 669.8 296.0 100.2 244.4 140.1 78.2 321.7 252.0 126.1 104.2 172.8 47.9
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Mean diosgenin content (%) of ten fenugreek genotypes grown at fourteen environments in southern Alberta. 
 Environments 
Genotype 
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Diosgenin Content (%) 
Tristar 0.50 0.57 0.52 0.61 0.55 0.56 0.54 0.49 0.51 0.48 0.51 0.51 0.52 0.51 
Quatro 
MP 30 0.61 0.71 0.70 0.65 0.69 0.68 0.64 0.66 0.69 0.63 0.71 0.65 0.67 0.59 
AC 
Amber 0.74 0.86 0.70 0.81 0.82 0.91 0.82 0.76 0.90 0.80 0.85 0.80 0.79 0.78 
F17 0.41 0.45 0.48 0.54 0.51 0.50 0.49 0.54 0.53 0.53 0.48 0.53 0.50 0.47 
F96 0.56 0.59 0.57 0.69 0.61 0.72 0.55 0.62 0.61 0.57 0.61 0.58 0.59 0.62 
F75 0.60 0.59 0.62 0.63 0.59 0.64 0.60 0.58 0.53 0.62 0.59 0.57 0.59 0.57 
Ind 
Temp 0.57 0.64 0.56 0.65 0.59 0.69 0.59 0.60 0.60 0.65 0.67 0.64 0.63 0.58 
X92 0.71 0.83 0.68 0.81 0.76 0.85 0.68 0.68 0.73 0.82 0.78 0.70 0.74 0.68 
L3312 0.48 0.55 0.51 0.57 0.54 0.54 0.52 0.51 0.53 0.54 0.54 0.54 0.55 0.54 
F86 0.55 0.62 0.53 0.67 0.58 0.60 0.51 0.54 0.54 0.56 0.56 0.54 0.58 0.57 
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Mean diosgenin productivity (kg ha-1) of ten fenugreek genotypes grown at fourteen environments in southern Alberta. 
 Environments 
Genotype 
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Diosgenin Productivity (kg ha-1) 
Tristar 13.1 20.5 13.6 8.8 3.7 7.4 6.8 1.8 15.6 7.1 5.6 3.5 6.0 4.1 
Quatro 
MP 30 17.4 25.7 23.0 10.8 6.4 12.2 8.9 2.8 19.6 8.4 8.9 4.5 9.1 4.8 
AC 
Amber 12.5 22.2 11.3 13.9 7.0 10.1 8.9 2.6 17.2 11.6 3.3 3.8 6.6 5.7 
F17 11.1 18.4 9.2 9.0 5.0 7.4 6.9 1.3 11.0 8.0 4.7 3.9 6.1 3.1 
F96 18.3 20.7 15.0 12.4 5.4 12.2 5.8 2.6 15.4 9.0 4.7 3.6 7.1 4.2 
F75 20.8 22.7 23.8 11.4 5.8 12.6 7.7 1.8 14.8 9.2 5.6 3.5 8.3 3.9 
X92 13.6 16.2 3.6 11.2 2.8 9.5 5.7 2.9 9.1 7.8 6.2 3.8 8.5 4.8 
Ind Temp 9.4 10.0 5.6 7.7 4.3 5.2 5.7 1.0 10.9 7.1 5.0 2.1 5.5 3.2 
L3312 15.2 19.9 16.3 10.1 3.0 9.3 6.5 1.8 10.1 8.5 5.4 3.8 6.3 4.2 
F86 21.9 16.5 18.1 10.3 4.5 8.5 5.3 3.0 10.6 8.2 4.3 3.5 6.4 1.8 
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Mean 4-hydroxyisoleucine content (%) of ten fenugreek genotypes grown at fourteen environments in southern Alberta. 
 Environment 
Genotype 
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4-Hydroxyisoleucine Content (%) 
Tristar 0.83 0.82 0.88 0.75 0.84 0.99 1.00 1.46 0.92 0.75 1.22 1.24 1.22 1.01
Quatro 
MP 30  0.78 0.80 0.78 0.60 0.78 0.89 0.86 1.45 0.93 0.64 1.06 1.17 1.10 0.91
AC 
Amber 0.87 0.86 0.90 0.75 0.79 0.88 0.78 1.17 0.78 0.76 1.13 1.35 1.26 0.97
F17 0.90 0.83 0.90 0.63 0.82 0.90 0.93 1.12 0.94 0.77 1.13 1.10 1.08 0.90
F96 0.75 0.77 0.77 0.60 0.79 0.84 0.80 1.33 0.71 0.70 1.03 1.23 1.06 0.90
F75 0.99 0.89 0.78 0.73 0.89 0.89 1.04 1.40 0.89 0.77 0.98 1.30 1.13 1.08
X92 0.79 0.84 0.81 0.71 0.74 0.86 0.67 1.09 0.84 0.71 0.97 1.01 1.03 0.87
Ind  
Temp 0.91 0.82 0.91 0.73 0.82 1.02 0.96 1.35 0.64 0.76 0.92 1.39 1.41 1.22
L3312 0.83 0.70 0.91 0.74 0.78 0.90 0.89 1.15 0.77 0.77 1.04 1.13 0.99 1.00
F86 0.69 0.74 0.73 0.58 0.86 0.91 0.83 1.13 0.75 0.69 0.97 1.08 0.92 0.97
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Mean 4-hydroxyisoleucine productivity (kg ha-1) of ten fenugreek genotypes grown at fourteen environments in southern 
Alberta. 
 Environment 
Genotype 
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4-Hydroxyisoleucine Productivity (kg ha-1) 
Tristar 23.0 30.1 23.6 11.4 6.0 13.7 12.6 5.5 27.9 11.2 13.3 8.7 14.2 8.1
Quatro 
MP 30 23.4 29.8 26.3 10.5 7.6 17.0 11.9 6.3 26.6 8.5 13.4 8.2 15.0 7.4
AC 
Amber 15.5 22.6 15.2 13.4 7.1 10.3 8.5 4.0 14.8 10.9 4.4 6.3 10.6 7.2
F17 25.6 34.5 17.6 11.0 8.4 14.0 13.0 2.8 19.5 11.6 11.0 8.0 13.1 6.0
F96 25.8 27.6 20.9 11.5 7.4 15.0 8.5 5.6 18.1 11.0 7.9 7.6 12.7 6.0
F75 35.8 35.0 30.7 13.9 9.3 18.4 13.4 4.4 24.7 11.4 9.2 8.0 15.7 7.3
X92 15.8 16.8 4.4 10.3 2.9 10.1 5.6 4.6 10.5 6.8 7.8 5.5 11.8 6.1
Ind Temp 15.7 13.2 9.3 9.0 6.3 8.1 9.2 2.4 11.5 8.4 6.8 4.6 12.3 6.8
L3312 27.6 25.8 29.8 14.0 4.5 16.2 11.1 4.0 14.5 12.1 10.3 8.0 11.3 7.7
F86 28.9 20.4 26.2 9.5 7.0 13.6 8.8 6.3 14.8 10.0 7.4 6.9 10.2 3.1
 
